Agreement and Plan of Merger dated July 30, 2009 by and among FPIC Insurance Group, Inc., First Professionals Insurance Company, Inc., MFPIC Merger Corp., Advocate, MD Financial Group, Inc., and the Stockholders Representative.* * Schedules and certain exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant hereby agrees to furnish supplemental copies of any of the omitted schedules and exhibits upon request by the Securities and Exchange Commission

EX-2.1 2 exhibit2-1.htm AGREEMENT AND PLAN OF MERGER exhibit2-1.htm
Revised Exhibit 2.1



2202: STOCK PURCHASE AGREEMENT
 AGREEMENT AND PLAN OF MERGER


by and among


FPIC INSURANCE GROUP, INC.,


FIRST PROFESSIONALS INSURANCE COMPANY, INC.


FPIC MERGER CORP.,


ADVOCATE, MD FINANCIAL GROUP INC.,


The Stockholder Representative,


and


Certain Holders of Equity Interests


July 30, 2009

 
 

 

 
TABLE OF CONTENTS
 

 

   
§1.  Definitions 
 6
§2.  The Stock Purchase and the Merger
 13
       (a)  Solicitation of Joinder Agreements
 13
       (b)  Stock Purchase 
 13
       (c)  Short-Form Merger; Merger by Written Consent 
 14
       (d)  Stockholders’ Meeting 
 14
       (e)  Merger 
 15
       (f)  Withholding 
 19
       (g)  Stock Transfer Books 
 19
       (h)  Lost Certificates 
 19
       (i)  Effect of Payment 
 19
       (j)  Closing 
 19
       (k)  Deliveries at Closing 
 20
       (l)  Stockholders Representative 
 20
§3.  Representations and Warranties Concerning Transaction 
 24
       (a)  Sellers’ Representations and Warranties 
 24
       (b)  Buyer’s Representations and Warranties 
 26
§4.  Representations and Warranties Concerning Company and Its Subsidiaries 
 27
       (a)  Organization, Qualification, and Corporate Power; Authorization of Transaction 
 27
       (b)  Capitalization 
 28
       (c)  Non-contravention 
 28
       (d)  Brokers’ Fees 
 28
       (e)  Title to Tangible Assets 
 28
       (f)  Subsidiaries 
 29
       (g)  Financial Statements 
 29
       (h)  Legal Compliance 
 30
       (i)  Tax Matters 
 30
       (j)  Real Property 
 31
       (k)  Intellectual Property 
 31
       (l)  Contracts 
 32
       (m) Insurance 
 33
       (n)  Litigation 
 33
       (o)  Employee and Employee Benefit Matters 
 34
       (p)  Bank Accounts 
 36
       (q)  Information Technology 
 37
       (r)  Board Recommendations
 37
       (s)  Vote Required 
 37
       (t)  Absence of Sensitive Payments 
 37
       (u)  Books and Records 
 37
       (v)  Certain Business Relationships with Company and its Subsidiaries 
 38
       (w) Absence of Certain Developments or Changes 
 38
       (x)  Relationship with Customers 
 39
       (y)  Communications with Company Holders 
 40
 
 
 
2

 
 
 
§5.  Pre-Closing Covenants 
 40
       (a)  General 
 40
       (b)  Notices and Consents; Closing Reserve Study 
 40
       (c)  Operation of Business 
 40
       (d)  Full Access 
 41
       (e)  Notice of Developments 
 41
       (f)  Exclusivity 
 42
       (g)  Payments under Company 2009 Bonus Program 
 42
       (h)  Second Quarter Report 
 42
       (i)  Certain Employee Agreements 
 43
§6.  Post-Closing Covenants 
 43
       (a)  General 
 43
       (b)  Litigation Support 
 43
       (c)  Transition 
 43
       (d)  Officers’ and Directors’ Indemnification 
 43
       (e)  Seller Release 
 44
       (f)  Incentive Bonus Payments 
 45
§7.  Condition to Obligation to Close 
 45
       (a)  Conditions to Buyer’s Obligation 
 45
       (b)  Conditions to Sellers’, Stockholders Representative’s and Company’s Obligations
 
              To Close 
 47
       (c)  Conditions to the Merger Closing if the Stock Purchase Closing Has Occurred
 48
       (d)  Conditions to the Merger Closing is the stock Purchase Closing Has Not Occurred 
 49
§8.  Remedies for Breaches of This Agreement 
 49
       (a)  Survival of Representations and Warranties 
 49
       (b)  Indemnification Provisions for Buyer’s Benefit 
 49
       (c)  Indemnification Provisions for Sellers’ Benefit 
 50
       (d)  Matters Involving Third Parties 
 51
       (e)  Treatment of Insurance Proceeds in Relation to Indemnification Payments 
 52
       (f)  Exclusive Remedy 
 52
       (g)  Reduction of Additional Consideration 
 52
§9.  Termination 
 52
       (a)  Termination of Agreement 
 52
       (b)  Effect of Termination 
 53
§10.Employees; Benefits 
 53
       (a)  Continuation of Employment Immediately After Closing 
 53
       (b)  Change of Control 
 54
       (c)  Period of Service 
 54
       (d)  No Employee Third Party Beneficiaries 
 54
§11.Miscellaneous 
 54
       (a)  Nature of Sellers’ Obligations 
 54
       (b)  Nature of Buyer Obligations; Subsidiary Actions 
 55
       (c)  Press Release and Public Announcements 
 55
       (d)  No Third-Party Beneficiaries 
 55
       (e)  No Code §338 Election 
 55
       (f)  Entire Agreement 
 55
 
 
 
3

 
 
 
       (g)  Succession and Assignment 
 55
       (h)  Counterparts 
 55
       (i)  Headings 
 56
       (j)  Notices 
 56
       (k)  Governing Law 
 57
       (l)  Amendments and Waivers 
 57
       (m) Severability 
 57
       (n)  Expenses 
 57
       (o)  Construction 
 58
       (p)  Incorporation of Exhibits, Annexes, and Schedules 
 58
       (q)  Action by Stockholders Representative 
 58
       (r)  Dispute Resolution 
 58
   
Exhibit A-Form of Joinder Agreement
 
Exhibit B-Form of Earnout Agreement
 
Annex I- Exceptions to Sellers’ Representations and Warranties Concerning Transaction
 
Annex II- Exceptions to Buyer’s Representations and Warranties Concerning Transaction
 
   
 

 
4

 

 
AGREEMENT AND PLAN OF MERGER
 
This Agreement and Plan of Merger (this "Agreement") is entered into on July 30, 2009, by and among FPIC Insurance Group, Inc., a Florida corporation ("FIG"), First Professionals Insurance Company, Inc., a Florida stock insurance company and a direct wholly owned subsidiary of FIG (“FPIC” and, collectively with FIG, “Buyer”), FPIC Merger Corp., a Nevada corporation and a direct wholly owned subsidiary of FPIC (“Merger Co”), Advocate, MD Financial Group Inc., a Nevada corporation ("Company"), the individuals named herein as the Stockholders Representative, and the stockholders and warrant holders of the Company that execute and deliver to Company a joinder agreement (“Joinder Agreement”) in the form attached hereto as Exhibit A (each sometimes referred to herein as a “Seller” and collectively as the “Sellers”). Buyer, Merger Co, Company, Stockholders Representative and Sellers are referred to collectively herein as the "Parties" or in the singular as a "Party"

WHEREAS, the Boards of Directors of Buyer, Merger Co and Company have each determined that it is advisable and in the best interests of their respective companies and stockholders for Buyer to acquire Company upon the terms and subject to the conditions set forth herein;

WHEREAS, in furtherance of such acquisition, it is proposed that Company will use commercially reasonable efforts to cause the holders of its capital stock and warrants to enter into this Agreement (as it may be amended from time to time) by executing and delivering Joinder Agreements and to sell their interests in Company to Buyer on the terms and conditions hereof (the “Stock Purchase”);

WHEREAS, the Boards of Directors of Buyer and Merger Co have approved the transactions contemplated hereby, including the Stock Purchase;

WHEREAS, the Board of Directors of Company has (a) approved this Agreement and the merger transactions contemplated hereby involving the Company, (b) determined this Agreement to be in the best interest of Company and the holders of capital stock and warrants for capital stock of Company based upon industry trends and conditions, the current market for strategic transactions in such industry, input from the Company's investment bankers, requests made by Company Holders for liquidity and other considerations and circumstances as deemed by the Board of Directors to be relevant to such determination, and (c) resolved and agreed, subject to the terms and conditions contained herein, to recommend that holders of capital stock and warrants for capital stock of Company sell their interests as part of the Stock Purchase and to vote their Shares (as hereinafter defined) in favor of the Merger (as hereinafter defined);

WHEREAS, also in furtherance of such acquisition and in order to preserve the value and good will of Company and its Subsidiaries for Buyer, Mark E. Adams contemporaneously herewith is entering into an amended and restated Executive Employment Agreement with Company and a Non-Competition Agreement with Buyer and Company;


 

 

WHEREAS, also in furtherance of such acquisition, the Boards of Directors of Buyer, Merger Co and Company have each approved the merger of Merger Co with and into Company in accordance with the Nevada Revised Statutes (“Nevada Law”) pursuant to which each issued and outstanding Company Share (as hereinafter defined) not owned by Buyer and not constituting Dissenting Shares (as hereinafter defined) will be converted into the right to receive the per Company Share consideration paid pursuant to the Stock Purchase and upon the terms and subject to the conditions set forth herein;

WHEREAS, in order to induce Buyer and Merger Co to enter into this Agreement, concurrently herewith certain Company Holders (as hereinafter defined) are executing and delivering Joinder Agreements to Company contemporaneously with the execution and delivery of this Agreement by Buyer and Merger Co; and

WHEREAS, the parties hereto desire to make certain representations, warranties, covenants and agreements in connection herewith;

NOW, THEREFORE, in consideration of the premises and the mutual agreements and covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:
 
Section 1.        Definitions. 
 
"Additional Consideration" means the consideration, if any, payable to former Company Holders pursuant to the provisions of the Earnout Agreement.
 
"Additional Consideration Per Company Share" means an amount equal to the result obtained by dividing Additional Consideration by the aggregate number of Company Shares outstanding or subject to issuance on exercise of outstanding Company Warrants immediately before the Effective Time.
 
"Adverse Consequences" means all actions, suits, proceedings, hearings, investigations, charges, complaints, claims, demands, injunctions, judgments, orders, decrees, rulings, damages, dues, penalties, fines, costs, commercially reasonable amounts paid in settlement, liabilities, obligations, Taxes, Liens, losses, expenses, and fees, including court costs and reasonable attorneys' fees and expenses.
 
"Affiliate" has the meaning set forth in Rule 12b-2 of the regulations promulgated under the Securities Exchange Act.
 
"Affiliated Group" means any affiliated group within the meaning of Code §1504(a) or any similar group defined under a similar provision of state, local or foreign law.
 
"Allocable Portion" means with respect to the share of any Seller in a particular amount, that fraction equal to the number of Company Shares the Seller holds as set forth in Section 4(b) of the Disclosure Schedule over the total number of Company Shares.
 
"Annual GAAP Financial Statements" has the meaning set forth in Section 4(g)(i) below.
 
"Annual Report" has the meaning set forth in Section 4(g)(i) below.
 
"Applicable Rate" means the corporate base rate of interest publicly announced from time to time by Frost National Bank plus two percent (2.0%) per annum.
 

 
6

 

 
"Buyer" has the meaning set forth in the preface above.
 
"Buyer Knowledge Group" means any of John R. Byers, Charles Divita III and Robert White.
 
"Certificate of Merger" has the meaning set forth in Section 2(e)(i) below.
 
"Closing" means the closing of the Stock Purchase or the Merger, whichever first occurs, and the transactions to occur in conjunction with such closing as contemplated by this Agreement. References to the Stock Purchase Closing means only the Closing of the Stock Purchase and references to the Merger Closing means only the Closing of the Merger.
 
"Closing Consideration" means Thirty Three Million Six Hundred Thousand Dollars ($33,600,000), less (a) the amount of Incentive Bonus payable immediately before Closing, less (b) Excess Transaction Expenses, if any, and (c) less the amount, if any, of the Loss Reserves shown in the Most Recent Statutory Financial Statements that are less than 103% of the loss reserve amount shown in the Closing Reserve Study.
 
"Closing Consideration Per Company Share" means an amount equal to the result obtained by dividing the Closing Consideration by the aggregate number of Company Shares outstanding or subject to issuance on exercise of outstanding Company Warrants immediately before the Closing.
 
"Closing Date" has means the date on which Closing occurs and references to “Stock Purchase Closing Date” or “Merger Closing Date” shall mean the date on which the Stock Purchase or the Merger, respectively, occurs.
 
"Closing Reserve Study” means a study of the statutory loss reserves of the Insurance Company as of June 30, 2009, to be performed by Company Actuary and delivered to Company.
 
"Code" means the Internal Revenue Code of 1986, as amended.
 
"Company" has the meaning set forth in the preface above.
 
"Company Actuary" means Milliman, Inc.
 
"Company Group Benefit Plan" has the meaning set forth in Section 4(o)(i) below.
 
"Company Common Share" means any share of the Company Common Stock.
 
"Company Common Stock" means the common stock, par value $.005 per share, of Company.
 
"Company Employee" has the meaning set forth in Section 10(a) below.
 
"Company Group Employee Agreement" has the meaning set forth in Section 4(o)(i) below.
 
"Company Holder" means each holder of Company Common Stock, Company Preferred Stock or Company Warrants.
 
"Company Knowledge Group" means any of Mark E. Adams, Steven W. Loranger, Thomas J. Smith, or Timothy P. Reardon.
 
"Company Preferred Stock" means the preferred stock, par value $.005, Series A and Series B, of Company.
 

 

 

 
"Company Preferred Share" means any share of the Company Preferred Stock.
 
"Company Share" means any outstanding Company Common Share and any Company Common Share into which any outstanding Company Preferred Stock is convertible or for which any outstanding Company Warrant is exercisable.
 
"Company Warrant" means any warrant or other option that Company has issued to a holder that may be exercised for one or more Company Common Shares.
 
"Confidential Information" means any information concerning the business and affairs of Company and its Subsidiaries that is not already generally available to the public.
 
"Confidentiality Agreement" means the Confidentiality and Nondisclosure Agreement, dated December 3, 2008, between Buyer and Company.
 
"Contract" means any binding agreement, commitment, consensual obligation, promise, undertaking or contract (whether written or oral and whether express or implied), including but not limited to any such (a) employment and consulting agreements; (b) joint venture and partnership agreements; (c) agreements restricting the right of a Person to compete with any other Person; (d) loan agreements, indentures, promissory notes and conditional sales agreements, pledges, security agreements, deeds of trust, financing statements and all documents granting or evidencing a Lien on any assets or rights of a Person, and obligations of reimbursement to any issuer of a letter of credit; (e) guarantees and assumptions of any obligation of another Person; (f) undertakings related to the purchase or sale of assets; (g) agreements relating to capital expenditures; (h) licenses, whether as licensor or licensee, of any invention (whether patented or not), trade secret, know-how, copyright, trademark or trade name or other intellectual property, except for pre-packaged software; (i) Leases, including subleases of, and options relating to, real estate; (j) Leases as lessee or lessor of tangible personal property; (k) capitalized leases and sale-leasebacks; (l) data licensing, distribution, supply and development agreements and Internet or web-site agreements; (m) royalty agreements; (n) revocable and irrevocable powers of attorney and proxies; (o) software agreements, except for pre-packaged software; (p) promotional and advertising agreements; provided, however, the term “Contract” will not include oral agreements, oral commitments, oral consensual obligations, oral promises, oral undertakings or oral contracts not Known to Company or insurance policies or contracts (other than reinsurance policies or contracts), or commitments or proposals to issue or write insurance policies or contracts, issued or made by Company in the Ordinary Course of Business.
 
"Copyrights" means all registered and unregistered copyrights in both published works and unpublished works used by Company or any of its Subsidiaries.
 
"Disclosure Schedule" has the meaning set forth in Section 4 below.
 
"Dissenting Shares" has the meaning set forth in Section 2(e)(v) below.
 
"Earnout Agreement" means the Earnout Agreement between Buyer and Stockholders Representative, substantially in the form attached hereto as Exhibit B.
 
"Effective Time" has the meaning set forth in Section 2(e)(i) below.
 
"ERISA" means the Employee Retirement Income Security Act of 1974, as amended.
 

 
8

 

 
"Excess Transaction Expenses" means, if Extended Coverage is not obtained by Company prior to Closing, Transaction Expenses in excess of Five Hundred Thousand Dollars ($500,000) or, if Extended Coverage is obtained by Company prior to Closing, Transaction Expenses in excess of Five Hundred Fifty Thousand Dollars ($550,000), in either case to the extent incurred or accrued after June 30, 2009 and on or before the Closing Date.
 
"Extended Coverage" has the meaning set forth in Section 6(d) below.
 
"FIG" has the meaning set forth in the preface above.
 
"Financial Statements" has the meaning set forth in Section 4(g)(i) below.
 
"Fox-Pitt" means Fox-Pitt Kelton Cochran Caronia Waller, the investment banking firm that has represented Company in connection with the transactions contemplated by this Agreement.
 
"FPIC" has the meaning set forth in the preface above.
 
"GAAP" means accounting principles generally accepted in the United States as in effect from time to time, consistently applied.
 
 
"Governmental Body" means the government of the United States, any other nation or any political subdivision of any thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other Person exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government.
 
"hereunder," "hereof, " "hereto,"  and words of similar import shall be deemed references to this Agreement and its Annexes and Disclosure Schedule, as a whole, but not to the Exhibits and not to any particular Section or other provision hereof.
 
"Incentive Bonus" means five percent (5%) of the Closing Consideration (for purposes of this definition only, Closing Consideration shall be determined without giving effect to the reduction for the Incentive Bonus as stated in the definition of Closing Consideration) and, when determined and payable under the Earnout Agreement, of Additional Consideration, if any, to be allocated by Company's Board of Directors prior to Closing.
 
"Income Tax" means any federal, state, local, or foreign income tax measured by or imposed on net income, including any interest, penalty, or addition thereto, whether disputed or not.
 
"Income Tax Return" means any return, declaration, report, claim for refund, or information return or statement relating to Income Taxes, including any schedule or attachment thereto.
 
"Indemnification Ceiling" has the meaning set forth in Section 8(b)(i) below.
 
"Indemnified Party" has the meaning set forth in Section 8(d) below.
 
"Indemnifying Party" has the meaning set forth in Section 8(d) below.
 
"Insurance Subsidiary" means Advocate, MD Insurance Company of the Southwest, Inc.
 
"Intellectual Property Assets" means all intellectual property owned or licensed (as licensor or licensee) by Company or any of its Subsidiaries in which Company or any of its

 

 

Subsidiaries has a proprietary interest, including all Marks, patents, Copyrights, trade secrets, Net Names and rights in mask works.
 
"Joinder Agreement" has the meaning set forth in the preface above.
 
"June 30, 2009 Internal Financial Statements" has the meaning set forth in Section 4(g)(i) below.
 
"Knowledge" means actual knowledge without independent investigation, except that “Knowledge”, to a Person’s “Knowledge”, “known to” a Person or a similar phrase, with respect to Company, means the actual knowledge of any member of the Company Knowledge Group, and, with respect to Buyer, means the actual knowledge of any member of the Buyer Knowledge Group, as of the relevant date after reasonable inquiry given the nature of such individual’s position and responsibilities.
 
"Leased Real Property" means all leasehold or subleasehold estates and other rights to use or occupy any land, buildings, structures, improvements, fixtures, or other interest in real property that is used in Company's or any of its Subsidiaries' business.
 
"Leases" means all leases, subleases, licenses, concessions and other agreements (written or oral), including all amendments, extensions, renewals, guaranties, and other agreements with respect thereto, pursuant to which Company or any of its Subsidiaries holds any Leased Real Property or leases any equipment or other personal property.
 
"Legal Requirement" means any federal, state, local, municipal, foreign, international, multinational or other constitution, law, ordinance, principle of common law, code, regulation, order, statute or treaty.
 
"Letter of Transmittal" has the meaning set forth in Section 2(e)(vi)(B) below.
 
"Lien" means any mortgage, pledge, lien, encumbrance, charge, or other security interest.
 
"Loss Reserves" means Company’s estimate, which will be stated  net of any related reinsurance arrangements, of the amounts expected to be paid out in the future on account of all insured events and reflected in the Most Recent Statutory Financial Statements  (i.e., its “carried reserves”), and comprising estimated case reserves on reported claims (which include a provision for case reserve development to the expected ultimate amount) plus estimated insured losses and loss adjustment expenses incurred but not reported.   
 
"Marks" means the names of Company and each of its Subsidiaries and all assumed fictional business names, trade names, registered and unregistered trademarks, service marks and applications used by Company or any of its Subsidiaries.
 
"Material Adverse Effect" or "Material Adverse Change" means any effect or change that would be or is reasonably likely to be materially adverse to the financial condition, business or results of operations of Company and its Subsidiaries, taken as a whole, or to the ability of  Company or the Company Holders possessing the minimum requisite vote to approve the Merger to consummate timely the transactions contemplated hereby; provided that none of the following will be deemed to constitute, and none of the following will be taken into account in determining whether there has been, a Material Adverse Effect or Material Adverse Change: (a) any adverse change, event, development, or effect arising from or relating to (1) general business or economic conditions affecting the United States taken as a whole or the industries in which the
 

 
10

 

Company operates taken as a whole, to the extent not having a materially disproportionate effect on Company and its Subsidiaries taken as a whole, (2) national or international political or social conditions, including the engagement by the United States in hostilities, whether or not pursuant to the declaration of a national emergency or war, or the occurrence of any military or terrorist attack upon the United States, or any of its territories, possessions, or diplomatic or consular offices or upon any military installation, equipment or personnel of the United States, (3) financial, banking, or securities markets (including any disruption thereof and any decline in the price of any security or any market index), (4) changes in GAAP, (5) changes in laws, rules, regulations, orders, or other binding directives issued by any Governmental Body not having a materially disproportionate effect on Company and its Subsidiaries taken as a whole, or (6) the taking of any action contemplated by this Agreement and the other agreements contemplated hereby in accordance with the terms hereof, (b) any failure, in and of itself, by the Company or its Subsidiaries to meet any internal or published projections, forecasts or revenue or earnings predictions for any period ending on or after the date of this Agreement, (c) any existing event, occurrence, or circumstance relating to the  Company and its Subsidiaries with respect to which Buyer has, and Company does not have, Knowledge as of the date hereof, and (d) any adverse change in or effect on the business of the Company and its Subsidiaries that is cured (without a Material Adverse Effect or Material Adverse Change) by Sellers to the reasonable satisfaction of Buyer before the earlier of (1) the Closing Date and (2) the date on which this Agreement is terminated pursuant to Section 9 hereof.
 
"Merger" has the meaning set forth in Section 2(e)(i) below.
 
"Merger Closing Consideration" has the meaning set forth in Section 2(e)(iii)(A) below.
 
"Most Recent Financial Statements" has the meaning set forth in Section 4(g)(i) below.
 
"Most Recent GAAP Financial Statements" has the meaning set forth in Section 4(g)(i) below.
 
"Most Recent Statutory Financial Statements" has the meaning set forth in Section 4(g)(i) below.
 
"Net Names" means all rights in internet web sites and internet domain names presently used by Company or any of its Subsidiaries.
 
"Ordinary Course of Business" means the ordinary course of business of the subject Person consistent with past custom and practice (including with respect to quantity and frequency).
 
"Party" or "Parties" has the meaning set forth in the preface above.
 
"Person" means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization, any other business entity or a Governmental Body.
 
"Proportionate Share" means the product of (i) the total losses, damages and expenses described in Section 2(l)(v) below, and (ii) the percentage that the outstanding Company Shares owned, or subject to issuance on exercise of outstanding Company Warrants owned, by the referenced Company Holder constitutes of all Company Shares.
 

 
11

 

 
"Proxy Statement" means the proxy statement or information statements prepared for the Company Holders and describing the transactions contemplated in this Agreement, together with any amendments or supplements thereto.
 
"Purchase Price" means the sum of the Closing Consideration and the Additional Consideration, if any.
 
"Quarterly Report" has the meaning set forth in Section 4(g)(i) below.
 
"Secretary" has the meaning set forth in Section 2(e)(i) below.
 
"Securities Act" means the Securities Act of 1933, as amended.
 
"Securities Exchange Act" means the Securities Exchange Act of 1934, as amended.
 
"Seller" has the meaning set forth in the preface above.
 
"Share Certificates" means the certificates evidencing Company Common Shares or Company Preferred Shares.
 
"Shares" means the Company Common Shares or Company Preferred Shares.
 
"Software" means all computer software and subsequent versions thereof, including source code, object, executable or binary code, objects, comments, screens, user interfaces, report formats, templates, menus, buttons and icons and all files, data, materials, manuals, design notes and other items and documentation related thereto or associated therewith.
 
"Stockholders Representative" has the meaning set forth in Section 2(l) below.
 
"Subsidiary" means, with respect to any Person, any corporation, limited liability company, partnership, association, or other business entity of which (i) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers, or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof or (ii) if a limited liability company, partnership, association, or other business entity (other than a corporation), a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person or a combination thereof and for this purpose, a Person or Persons own a majority ownership interest in such a business entity (other than a corporation) if such Person or Persons will be allocated a majority of such business entity's gains or losses or will be or control any managing director or general partner of such business entity (other than a corporation). The term "Subsidiary" will include all Subsidiaries of such Subsidiary.
 
"Surviving Corporation" has the meaning set forth in Section 2(e)(i) below.
 
"Tax" or "Taxes" means any federal, state, local, or foreign Income Tax, gross receipts, license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits, environmental (including taxes under Code §59A), customs duties, capital stock, franchise, profits, withholding, social security (or similar), unemployment, disability, real property, personal property, sales, use, transfer, registration, value added, alternative or add-on minimum, estimated, or other tax of any kind whatsoever, including any interest, penalty, or addition thereto, whether disputed or not.
 

 
12

 

 
"Tax Return" means any return, declaration, report, claim for refund, or information return or statement relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof.
 
"Third Party Claim" has the meaning set forth in Section 8(d) below.
 
"Transaction Expenses" means the expenses of Stockholders Representative paid or payable by Company pursuant to Section 2(l)(v) below, and the expenses of Company and its Subsidiaries, incurred prior to Closing in connection with the transactions contemplated hereby, but shall not include an accrual, if any prior to Closing, of severance pay for Mark E. Adams or the expenses of Company’s 2009 employee bonus program.
 
"Warrant Certificate" means the certificates or other documents representing or comprising Company Warrants.
 
"Warrant Merger Closing Consideration" has the meaning set forth in Section 2(e)(iv) below.

Section 2.         The Stock Purchase and the Merger.

(a)           Solicitation of Joinder Agreements.  Between the date hereof and the Closing Date, Company and the Stockholder Representative will use commercially reasonable  efforts to obtain the execution and delivery of a Joinder Agreements from each Company Holder, together with (i) the Share Certificates and Warrant Certificates evidencing any Shares and Company Warrants held by such Company Holder, (ii) stock transfer powers executed in blank with respect to such Shares, (iii) proxies naming the Stockholders Representative as the Company Holders proxy with directing the Stockholders Representative to vote or give a written consent with respect to the Shares held by such Company Holder to approve this Agreement and the Merger and to vote or give a written consent with respect to such Shares on any other matters that may be presented at the Special Meeting of Company Holders and any adjournment thereof, and (iv) a notice of exercise of any Company Warrants held by such Company Holder that becomes effective immediately before the Closing.

(b)           Stock Purchase.   On and subject to the terms and conditions of this Agreement, at the Stock Purchase Closing, (i) the Stockholders Representative will, acting as attorney-in-fact for each Seller pursuant to its power authority granted in Section 2(l) below, take all such actions (other than payment of the exercise price) as may be necessary to exercise each Company Warrant held by a Seller into or for Company Shares; and (ii) following the completion of such exercises of Company Warrants, either FIG or FPIC will purchase (with the allocable portions to be purchased by each to be determined by Buyer in its discretion) from each Seller, and each Seller agrees to sell to such Buyer, each of his, her, or its Shares (and specifically authorizes the Stockholders Representative to deliver to such Buyer the Share Certificates evidencing such Shares together with the related stock transfer powers) for the Closing Consideration Per Company Share (less, in the case of Company Shares issued pursuant to the exercise of Company Warrants at the Closing without payment of the exercise price as contemplated by the previous provisions of this Section 2(b), the exercise price for such Company Shares).  Buyer agrees to pay, without interest, the amounts due to each Seller by wire transfer or delivery of other immediately available funds either to the account designated for such purpose by such Seller in the Joinder Agreement or, if no such account is designated, by Buyer's check payable to

 
13

 
 
the Seller and mailed to the Seller’s address specified in the Joinder Agreement. Each Seller will also be entitled to receive from Buyer any Additional Consideration Per Company Share in respect of each Share sold by such Seller as part of the Stock Purchase, which will be payable at the times and in the manner specified in the Earnout Agreement.

(c)           Short-Form Merger; Merger by Written Consent.  In the event that the Sellers hold Shares or Company Warrants representing at least 90% of the Company Shares (other than Company Shares subject to issuance on exercise of outstanding Company Warrants held by Persons other than Sellers), the Parties will, at the request of Buyer, take all necessary and appropriate action to cause the Merger to become effective upon the Closing, or as soon as practicable thereafter, without a Special Meeting of Holders of Shares, in accordance with Section 92A.180 of Nevada Law or pursuant to the immediately following sentence.  In the event that the Sellers hold Shares or Company Warrants representing at least a majority of the total voting power of the Shares and of each class of Company Preferred Stock, the Parties will, if requested by Buyer, take all necessary and appropriate action, including without limitation by executing appropriate consents in writing under Section 78.320 of Nevada Law, to cause the Merger to be approved by Company Holders and to become effective, whether or not the Stock Purchase Closing has occurred, as soon as practicable, without a Special Meeting of Holders of Shares.

(d)           Stockholders' Meeting.  In the event that the Sellers hold Shares or Company Warrants representing at least a majority of the total voting power of the Shares and of each class of Company Preferred Stock, and if Buyer is not required and does not choose to effect the Merger in accordance with Section 2(c) above, Company and the Stockholders Representative will, in accordance with applicable Legal Requirements and Company’s Articles of Incorporation and Bylaws, (i) duly call, give notice of, convene and hold an annual or special meeting of the holders of its Shares as soon as practicable following the satisfaction or waiver of all conditions contained in Section 7(a) and Section 7(b) below, other than the condition contained in Section 7(a)(x) (concerning Company Holders representing 90% of all Company Shares having consented to the Merger and, if the Stock Purchase Closing has not then occurred, other than conditions with respect to actions the respective Parties are contemplated hereby to take at the Closing itself) for the purpose of considering and taking action on this Agreement and the transactions contemplated hereby, (ii) include in the Proxy Statement the recommendation of Company’s Board of Directors that the Company Holders approve this Agreement, the Merger and the transactions to be consummated in connection with the Merger Closing, and(iii)  use their commercially reasonable efforts to obtain such approval.  To the extent permitted by applicable Legal Requirements, Buyer and Merger Co each agree, and, if the Stock Purchase Closing has not then occurred, each Seller agrees to vote all Company Shares beneficially owned by such Person in favor of the Merger.  Buyer may elect in connection with a Merger effected pursuant to this Section 2(d) to forego the Stock Purchase and the other actions contemplated by Section 2(b) above, in which event the Sellers, and their Company Shares, will be treated in the manner contemplated by the Merger. The Parties will take all necessary and appropriate action to cause the Merger to become effective immediately upon conclusion of such shareholders meeting, or as soon as practicable thereafter, in accordance with Nevada Law.

 
14 

 

 
 (e)           Merger.

(i)         The Merger; Effective Time; Effect of Merger.  On and subject to the terms and conditions of this Agreement, and in accordance with Nevada Law, at the Effective Time, Merger Co will be merged with and into Company (the "Merger").  As a result of the Merger, the separate corporate existence of Merger Co will cease and Company will continue as the surviving corporation of the Merger (the “Surviving Corporation”).  The Parties will cause the Merger to be consummated by filing on the Merger Closing Date a certificate of merger (the “Certificate of Merger”) with the Secretary of State of the State of Nevada (the “Secretary”) in such form as is required by, and executed in accordance with the relevant provisions of, Nevada Law.  The effect of the Merger will be as provided in the applicable provisions of Nevada Law.  The term “Effective Time” means the date and time of the filing of the Certificate of Merger with the Secretary (which will be upon the Merger Closing or as soon as practicable thereafter, or such later time as may be agreed in writing by Buyer and Stockholders Representative and specified in the Certificate of Merger).

(ii)        Articles of Incorporation; Bylaws; Officers and Directors.  At the Effective Time and subject to the provisions of Section 6(d) below;

(A) with respect to a Merger pursuant to Section 2(c) above, the Articles of Incorporation and Bylaws of Surviving Corporation, as in effect immediately prior to the Effective Time, will be the Articles of Incorporation and Bylaws of the Surviving Corporation until thereafter amended as permitted by Nevada Law;

(B) with respect to a Merger pursuant to Section 2(d) above, (1) the Articles of Incorporation of Merger Co, as in effect immediately prior to the Effective Time, will be the Articles of Incorporation of the Surviving Corporation until thereafter amended as permitted by Nevada Law provided that the name will be Advocate, MD Financial Group Inc., and (2) the Bylaws of Merger Co, as in effect immediately prior to the Effective Time, will be the Bylaws of the Surviving Corporation until thereafter amended as provided by Nevada Law and such Bylaws; and

  (C) the directors of Merger Co immediately prior to the Effective Time will be the initial directors of the Surviving Corporation, each to hold office in accordance with the Articles of Incorporation and Bylaws of the Surviving Corporation until a successor is elected or appointed and has qualified or until the earliest of such director’s death, resignation, removal or disqualification, and the officers of Merger Co immediately prior to the Effective Time will be the initial officers of the Surviving Corporation, in each case until their respective successors are duly elected or appointed and qualified, or as otherwise provided in the Bylaws of the Surviving Corporation.

 
15

 


(iii)           Conversion of Securities.  At the Effective Time, by virtue of the Merger and without any action on the part of Merger Co, Company or the Company Holders:

(A) Each Company Common Share and each Company Preferred Share issued and outstanding immediately prior to the Effective Time (other than any such Shares that are to be canceled pursuant to Section 2(e)(iii)(B) below and any Dissenting Shares (as hereinafter defined)) will be canceled and will be converted automatically into the right to receive, upon surrender, in the manner provided in Section 2(e)(vi) below, of the certificate that formerly evidenced such share, (x) an amount equal to the Closing Consideration Per Company Share in cash payable, without interest, to the Company Holder of such Share (the “Merger Closing Consideration”) and (y) amounts equal to the Additional Consideration Per Company Share payable at the times and in the manner specified in the Earnout Agreement.  All such Shares when so converted will no longer be outstanding and will automatically be cancelled and retired and each Company Holder of a Share Certificate evidencing such Shares will cease to have any rights with respect thereto, except the right to receive the Closing Consideration Per Company Share and any Additional Consideration Per Company Share with respect to such Shares, without interest;

(B) Each Share held in the treasury of Company and each Share owned by Merger Co, FIG or FPIC or any direct or indirect wholly owned subsidiary of FIG, FPIC or Company immediately prior to the Effective Time will be cancelled without any conversion thereof and no payment or distribution will be made with respect thereto; and

(C) Each share of Common Stock, par value $0.005 per share, of Merger Co issued and outstanding immediately prior to the Effective Time will be converted into and exchanged for one validly issued, fully paid and nonassessable share of Common Stock, par value $0.005 per share, of the Surviving Corporation and will constitute the only outstanding shares of capital stock of the Surviving Corporation.

(iv)           Company Warrants.  Immediately after the Effective Time, each outstanding Company Warrant will, subject to Company’s receipt of any required consent of the holders of such Company Warrants, be cancelled by the Surviving Corporation, and each holder of a cancelled Company Warrant will be entitled to receive (A) from the Surviving Corporation at the same time as payment of the Merger Closing Consideration for Company Common Shares and Company Preferred Shares is made by the Surviving Corporation in connection with the Merger, in consideration for the cancellation of such Company Warrant, an amount in cash equal to the product of (x) the number of Company Shares previously subject to issuance on exercise of such Company Warrant and (y) the excess, if any, of the Closing Consideration Per Company Share over the exercise price per Company Share previously subject to issuance on exercise of such Company Warrant (the “Warrant Merger Closing Consideration”), and (B) from Buyer, any Additional Consideration Per Company Share in respect of the Company Shares previously subject

 
16 

 

to issuance on exercise of such Company Warrant, which will be payable at the times and in the manner specified in the Earnout Agreement.  Each Company Warrant that is not canceled as described above will continue to have, and be subject to, the same terms and conditions set forth in the applicable Company Warrant, except that each of the Company Shares for which such Company Warrant is exercisable will at the Effective Time be converted into the right to receive an amount in cash equal to the Closing Consideration Per Company Share for each Company Share subject to issuance on exercise of such Company Warrant and any Additional Consideration Per Company Share that will become payable under the Earnout Agreement after date of exercise of such Company Warrant.

(v)         Dissenting Shares.  Notwithstanding any provision of this Agreement to the contrary, Company Common Shares and Company Preferred Shares that are outstanding immediately prior to the Effective Time and that are held by Company Holders who are not Sellers and who will not have voted in favor of the Merger or consented thereto in writing and who will have timely demanded dissenters’ rights in accordance with applicable Nevada Law (collectively, the “Dissenting Shares”) will not be converted into or represent the right to receive the Merger Consideration.  Such  Company Holders will be entitled to receive payment of such consideration as may be determined to be due in respect of such Dissenting Shares held by them in accordance with the provisions of Nevada Law, except that all Dissenting Shares held by Company Holders who effectively will have withdrawn or lost their rights to demand appraisal of such Dissenting Shares under Nevada Law will thereupon be deemed to have forfeited such dissenters’ rights and converted into and to have become exchangeable for, as of the Effective Time, the right to receive the Merger Closing Consideration, without any interest thereon, upon surrender, in the manner provided in Section 2(e)(vi) below, of the Share Certificate or Share Certificates that formerly evidenced such Shares.  Company will give Buyer (i) prompt notice of any written notice of intent to seek dissenters’ rights received by Company and (ii) the opportunity to direct all negotiations and proceedings with respect to any such notices.  Company will not, without the prior written consent of Buyer, voluntarily make any payment with respect to, or settle, offer to settle, or otherwise negotiate with respect to, any such notices or demands.

(vi)   Surrender of Shares; etc.

(A) At and after the Effective Time, Buyer will cause the Surviving Corporation to have sufficient funds to pay the Merger Closing Consideration and other amounts, other than Additional Consideration, payable to Company Holders as a result of the Merger.  Pending such payment, such funds will be invested as desired by the Surviving Corporation; provided, however, that no loss on any investment made pursuant to this Section 2(e)(vi) will relieve Buyer or the Surviving Corporation of its obligation to pay the full amount of its obligations to Company Holders as a result of the Merger.  Any and all interest and earnings on such funds will be paid to FPIC or retained by the Surviving Corporation.

 
17

 

(B) Promptly after the Effective Time, Buyer will cause the Surviving Corporation to mail to each Person who was, at the Effective Time, a holder of record of Company Common Shares or Company Preferred Shares entitled to receive the Merger Closing Consideration pursuant to Section 2(e)(iii)(A) above, or a holder of Company Warrants entitled to receive the Warrant Merger Closing Consideration pursuant to Section 2(e)(iv) above, a form of letter of transmittal (the “Letter of Transmittal”) and instructions for use in effecting the surrender of the Share Certificates and Warrant Certificates, and acknowledgment of cancelation of any Company Warrants, pursuant to the Letter of Transmittal which will specify that delivery will be effected, and risk of loss and title to will pass, only upon proper delivery of the Share Certificates and Warrant Certificates to the Surviving Corporation.  Upon surrender to the Surviving Corporation of a Share Certificate, together with the Letter of Transmittal, duly completed and validly executed in accordance with the instructions thereto, and such other documents as may be required pursuant to such instructions, the holder of such Share Certificate will be entitled to receive in exchange therefor the Merger Closing Consideration for each Company Common Share or Company Preferred Share formerly evidenced by such Share Certificate, and such Share Certificate will then be canceled.  Upon acknowledging cancelation of a Company Warrant and delivery of a Warrant Certificate in accordance with the Letter of Transmittal and delivery of the Letter of Transmittal, duly completed and validly executed in accordance with the instructions thereto, and such other documents as may be required pursuant to such instructions, the holder of the canceled Company Warrant will be entitled to receive in exchange therefor the Warrant Merger Closing Consideration for such Company Warrant.  Until surrendered as contemplated by this Section 2(e)(vi)(B), each Share Certificate (other than Share Certificates representing Dissenting Shares) will be deemed at any time after the Effective Time to represent only the right to receive upon such surrender the amount of cash, without interest, equal to the Closing Consideration Per Company Share with respect to the Shares represented by such Share Certificate immediately before the Effective Time.  No interest will accrue or be paid on the Merger Closing Consideration payable upon the surrender of any Share Certificate for the benefit of the holder of such Share Certificate or on the Warrant Merger Closing Consideration payable upon acknowledgment of cancelation of a Company Warrant by delivery of a transmittal letter for the benefit of the holder of such canceled Company Warrant.  If payment of the Merger Closing Consideration is to be made to a Person other than the Person in whose name the surrendered Share Certificate is registered on the records of Company, it will be a condition of payment that the Share Certificate so surrendered will be endorsed properly or otherwise be in proper form for transfer and that the Person requesting such payment will have paid all transfer and other taxes required by reason of the payment of the Merger Closing Consideration to a Person other than the registered holder of the Share Certificate surrendered or will have established to the satisfaction of the Surviving Corporation that such taxes either have been paid or are not applicable.  The Surviving Corporation will pay all charges and expenses in connection with the distribution of the Merger Closing Consideration 

 
18 

 

and the Warrant Merger Closing Consideration other than the postage or other cost of delivering the letters of transmittal and accompanying Share Certificates and documents to the Surviving Corporation.

(C) Company Holders will be entitled to look to the Surviving Corporation  and Buyers (subject to abandoned property, escheat and other similar laws) only as general creditors thereof with respect to any Merger Closing Consideration or Warrant Merger Closing Consideration that may be payable to them.  Notwithstanding the foregoing, neither the Surviving Corporation nor Buyer will be liable to any Company Holder for any Merger Closing Consideration nor Warrant Merger Closing Consideration delivered to a public official pursuant to any abandoned property, escheat or other similar law in respect of Company Common Stock, Company Preferred Stock or Company Warrants held by such Company Holder.

 (f) Withholding.  Buyer or the Surviving Corporation, as the case may be, will be entitled to deduct and withhold from the consideration otherwise payable to any Company Holder pursuant to this Agreement such amounts as may be required to be deducted and withheld with respect to the making of such payment under the Code, or under any provision of state, local or foreign Tax law and promptly following any such deduction or withholding shall remit any sums so deducted or withheld to the appropriate taxing authority.  If such amounts are withheld, such amounts will be treated for all purposes of this Agreement as having been paid to the Common Holder in respect of which the Buyer or the Surviving Corporation, as applicable, made such deduction and withholding.

(g) Stock Transfer Books.  At the close of business on the day of the Effective Time, the stock transfer books of Company will be closed and, thereafter, there will be no further registration of transfers of Company Common Shares or Company Preferred Shares on the records of Company.  From and after the Effective Time, the Company Holders of Company Common Shares, Company Preferred Shares or Company Warrants outstanding immediately prior to the Merger Closing will cease to have any rights with respect to such shares except as otherwise provided herein or by applicable Legal Requirements.

(h) Lost Certificates.  If any Share Certificate will have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such Share Certificate to be lost, stolen or destroyed and, if required by the Surviving Corporation, an affidavit made by the Stockholder Representative that such Person is a Company Holder, the Surviving Corporation will pay, in exchange for such affidavit claiming such Share Certificate is lost, stolen or destroyed, the Closing Consideration Per Company Share to be paid in respect to the Shares represented by such Share Certificate, as contemplated by this Section 2 and any Additional Consideration Per Company Share as contemplated by the Earnout Agreement.

(i) Effect of Payments.  All cash paid upon delivery or surrender of Share Certificates or cancelation or exercise of Company Warrants in accordance with the terms of this Section 2 will be deemed to have been paid in full satisfaction of all rights pertaining to the Shares previously represented by such Share Certificates and all rights pertaining to such Company Warrants.

 
19 

 


(j) Closing.   The Stock Purchase Closing if any, and the Merger Closing will take place on the second business day following the satisfaction or waiver of the conditions applicable to such Closing pursuant to Section 7 below (other than conditions with respect to actions the respective Parties will take at the Closing itself or after the Closing as contemplated by this Agreement and the Earnout Agreement) or such other date  as Buyer and Company may mutually determine, and will take place at such time and place as Buyer and Company may mutually determine.

(k) Deliveries at Closing. At the Closing, (i) Buyer, Company and Stockholders Representative (acting on behalf of the Company Holders) will execute and deliver the Earnout Agreement, (ii) Company will cause the directors of each of its Subsidiaries to execute and deliver resignations as directors of such Subsidiaries, (iii) Company will cause each of its directors other than such directors who are Stockholders Representative to resign from Company’s Board of Directors and such directors who are Stockholders Representative will fill the resulting vacancies with nominees named by Buyer, and (iv)(A) each of the Sellers, or the Stockholders Representative on behalf of any Seller, and Company will deliver to Buyer the certificate as to his, her or its compliance with and performance of his, her or its covenants and obligations to be performed or complied with at or before the Closing and the various certificates, instruments, agreements and documents to be delivered by such Person at or before the Closing, and (B) each of FIG, FPIC and Merger Co will deliver to Sellers the certificate as to its compliance with and performance of its covenants and obligations to be performed or complied with at or before the Closing and the various certificates, instruments, agreements and documents to be delivered by such Person at or before the Closing, and (C) at the Stock Purchase Closing Buyer will make the payments specified in Section 2(b) above.  Immediately before Closing, Company will deliver the amount of Incentive Bonus to be paid before Closing to the Persons pursuant to the allocations determined by the Company’s Board of Directors and, if requested by Company for such purpose, Buyer will, immediately before Closing, advance Company the funds required for such purpose.

(l) Stockholders Representative. 

(i) By the execution and delivery of the Joinder Agreement, each Seller hereby irrevocably constitutes and appoints, and by virtue of executing and delivering a  Letter of Transmittal each Company Holder that executes and delivers a Letter of Transmittal  thereby irrevocably will constitute and appoint, and by virtue of the approval and adoption of this Agreement, the Merger and the other transactions contemplated hereby by the requisite vote of holders of Shares, each other Company Holder irrevocably constitutes and appoints, Mark E. Adams and Timothy P. Reardon acting jointly as his, her or its true and lawful agent and attorney-in-fact (such individuals collectively, the "Stockholders Representative"), with full power of substitution to act in such Company Holder's name, place and stead with respect to all matters to be performed by the Stockholders Representative expressly set forth in this Agreement, the Earnout Agreement and any other document, instrument or certificate executed in connection with the transactions contemplated hereby, and to act on such Company Holder's behalf in any dispute, litigation or arbitration involving this Agreement, and to do or refrain from doing
 
 
20

 
 
 
all such further acts and things, and execute all such documents as the Stockholders Representative will deem necessary or appropriate in all such connection with the transactions contemplated by this Agreement, including, without limitation, the power:
 
(A) to waive any condition to the obligations of any Seller to consummate the transactions contemplated by this Agreement;

(B) to execute and deliver all ancillary agreements, certificates and documents, and to make representations and warranties therein, on behalf of any Seller, or other Company Holder, that the Stockholders Representative deems necessary or appropriate in connection with the consummation of the transactions contemplated by this Agreement;

(C) to give and receive notices (including service of process) and communications on behalf of the Company Holders under this Agreement, the Earnout Agreement and any other document, instrument or certificate executed in connection with the transactions contemplated hereby and thereby;

(D) to execute any amendment or modification to this Agreement and the Earnout Agreement on behalf of the Company Holders;

(E) without limiting the foregoing provisions of this Section 2(l)(i), to take any action (or determine to take no action) in connection with the defense, settlement, compromise, arbitration and/or other resolution, including compliance with any order, of any claim for indemnification by or against any Company Holder, or  any other claim, arbitration, dispute, action, suit or other proceeding brought on behalf of or against any Company Holder, in connection with this Agreement, the Earnout Agreement and any other document, instrument or certificate executed in connection with the transactions contemplated hereby or thereby;

(F) to assert, bring, prosecute, maintain, settle, compromise, arbitrate and/or otherwise resolve on behalf of the Company Holders any claim by or against any Company Holder for indemnification or any other claim, arbitration, dispute, action, suit, or other proceeding by or against any Company Holder in connection with this Agreement, the Earnout Agreement and any other document, instrument or certificate executed in connection with the transactions contemplated hereby and thereby;

(G) to do or refrain from doing any further act or deed on behalf of each Company Holder which the Stockholders Representative deems necessary or appropriate in its sole discretion relating to the subject matter of this Agreement, the Earnout Agreement and any other document, instrument or certificate executed in connection with the transactions contemplated hereby and thereby, as fully and completely as such Company Holder could do if personally present; and

 
21

 
 
(H) to engage and hire other Persons (e.g. attorneys, accountants, consultants) in connection with the foregoing provisions of this Section 2(l)(i).
 
(ii) Any claim, arbitration, action, suit, or other proceeding, whether in law or equity, to enforce any right, benefit or remedy granted to Company Holders under this Agreement, the Earnout Agreement and any other document, instrument or certificate executed in connection with the transactions contemplated hereby and thereby will be asserted, brought, prosecuted or maintained only by the Stockholder Representative. 

(iii) The appointment of the Stockholders Representative will be deemed coupled with an interest and, subject to Section 2(l)(viii) below, will be irrevocable, and Buyer, Company, each of their Affiliates and any other Person may conclusively and absolutely rely, without inquiry, upon any action, decision or instruction of the Stockholders Representative on behalf of Company Holders in all matters referred to herein. All notices delivered by Buyer or the Surviving Corporation (following the Closing) to the Stockholders Representative (whether pursuant hereto or otherwise) for the benefit of Company Holders will constitute notice to the Company Holders.

(iv) The Stockholders Representative will act for the Company Holders on all of the matters set forth in this Agreement, the Earnout Agreement and any other document, instrument or certificate executed in connection with the transactions contemplated hereby and thereby in the manner the Stockholders Representative believes to be  appropriate for Company Holders representing a majority or more of the Company Shares and consistent with its obligations under this Agreement, the Earnout Agreement and any other document, instrument or certificate executed in connection with the transactions contemplated hereby and thereby, but the Stockholders Representative will not be responsible to the Company Holders for any loss or damages it or they may suffer by reason of the performance by the Stockholders Representative of its duties under this Agreement, the Earnout Agreement and any other document, instrument or certificate executed in connection with the transactions contemplated hereby and thereby, other than loss or damage arising from fraud or willful violation of Legal Requirements. The Stockholder Representative will not be entitled to receive any compensation for performing such role.

(v) The Company will pay the reasonable out-of-pocket expenses of Stockholders Representative, either directly to the payee or by reimbursement, incurred in connection with the transactions contemplated hereby (including, without limitation, the cost of legal counsel retained by the Stockholders Representative on behalf of the Company Holders) through Closing, promptly upon request of Stockholders Representative.  The Company Holders, jointly and severally, agree to indemnify and hold harmless the Stockholders Representative from any loss, damage or expense arising from the performance of its duties as the Stockholders Representative hereunder, but excluding any expense payable by Company pursuant to the preceding sentence and any loss or damage arising from fraud or willful violation of Legal Requirements by the Stockholders Representative.  Each Company Holder paying more than its Proportionate Share shall be entitled to contribution from any Company Holder paying less than its Proportionate Share.

 
22

 


(vi)  All actions, decisions and instructions of the Stockholders Representative taken, made or given pursuant to the authority granted to the Stockholders Representative pursuant to this Section 2(l) will be conclusive and binding upon each Company Holder, and no Stockholder will have the right to object, dissent and protest or otherwise contest the same.

(vii) This Section 2(l) is not intended to, and does not, create or impose any fiduciary duty on any current or future Stockholders Representative. Each Company Holder acknowledges and agrees that: (A) Buyer requires appointment of the Stockholders Representative to reduce the burden of dealing with numerous Company Holders; (B) the Stockholders Representative has agreed to undertake this obligation without compensation solely as an accommodation to the other Company Holders; (C) the Stockholders Representative is engaged in a broad range of transactions, including without limitation ongoing employment and relationships with Company extending beyond the Closing, which may involve interests that differ from those of the Company Holders, and the Stockholders Representative has no obligation to disclose such interests and transactions to the Company Holders by virtue of any fiduciary, advisory or agency relationship; and (D) the duties and obligations of the Stockholder Representative are strictly contractual and are limited to those expressly set forth in this Section 2(l). To induce the Stockholders Representative named in this Agreement and as may hereafter be appointed to serve in such capacity, each Company Holder hereby waives and disclaims, to the fullest extent permitted by law, any and all duties arising at law or in equity, including without limitation all fiduciary duties, and all claims he, she or it may have against the Stockholders Representative for breach of any duty arising out of or in connection with actions or omissions of the Stockholders Representative pursuant to this Section 2(l).

(viii) By affirmative vote of the Company Holders who represented at least a majority of the Company Shares immediately prior to Closing, new Stockholders Representatives may appointed and one or more Stockholders Representative may be removed and replaced at any time without cause; provided that no appointment, removal or replacement shall be binding or effective as to the Buyer or Company until its receipt of notice pursuant to Section 11(j) from the Company Holders taking such action, and no removal shall be permitted that would result in no Stockholders Representative at any time.  A Stockholders Representative (other than the sole Stockholders Representative) may resign at any time by written notice to Company and simultaneously mailing a copy of such resignation to the former Company Holders at their respective last addresses known to the resigning Stockholders Representative. A sole Stockholders Representative may only resign by at least sixty (60) days prior written notice to the Company and simultaneously mailing a copy of such resignation to the former Company Holders at their respective last addresses known to the resigning Stockholders Representative.

(ix) The provisions of this Section 2(l) are independent and severable, will constitute an irrevocable power of attorney, coupled with an interest and surviving death or dissolutions, granted by the Company Holders to the Stockholders Representative, will

 
23 

 

be enforceable notwithstanding any rights or remedies that any Company Holder may have, and will be binding upon the executors, heirs, legal representatives, successors and assigns of each such Company Holder.


Section 3.         Representations and Warranties Concerning Transaction. 

(a) Sellers' Representations and Warranties.  Each Seller severally and individually and not jointly represents and warrants to Buyer that the statements contained in this Section 3(a) are correct and complete as of the date of this Agreement and as of the date of execution of the Joinder Agreement by such Seller with respect to himself, herself, or itself, except as set forth in Annex I attached hereto or to the Joinder Agreement executed by such Seller.

(i) Organization of Certain Sellers. Seller (if a corporation or other entity) is duly organized, validly existing, and in good standing under the Legal Requirements of the jurisdiction of its incorporation (or other formation).

(ii) Authorization of Transaction. Seller has full power and authority (including full corporate or other entity power and authority) to execute and deliver this Agreement and to perform his, her, or its obligations hereunder. This Agreement constitutes the valid and legally binding obligation of Seller, enforceable in accordance with its terms except as such enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors’ rights or by general principles of equity.  Seller need not give any notice to, make any filing with, or obtain any authorization, consent, or approval of any Governmental Body or other Person in order to consummate the transactions contemplated by this Agreement. The execution, delivery and performance of this Agreement and all other agreements contemplated hereby have been duly authorized by Seller.

(iii) Non-contravention. Neither the execution and delivery of this Agreement, nor the consummation of the transactions contemplated hereby, will, with respect to Seller,: (A) violate any constitution, statute, regulation, rule, injunction, judgment, order, decree, ruling, charge, or other restriction of any Governmental Body to which Seller is subject or, if Seller is an entity, any provision of its charter, bylaws, or other governing documents, (B) conflict with, result in a breach of, constitute a default under, result in the acceleration of, create in any party the right to accelerate, terminate, modify, or cancel, or require any notice under any Contract or other arrangement to which Seller is a party or by which he, she, or it is bound or to which any of his, her, or its assets is subject, or (C) result in the imposition or creation of a Lien upon or with respect to his, her or its Company Common Shares, other Company Shares, Company Preferred Shares, or Company Warrants.
 
(iv)  Brokers' Fees.  Except for the Company’s obligations to Fox-Pitt as its financial advisor with respect to the transactions contemplated by this Agreement, Seller
 
 
24 

 
 

has no liability or obligation to pay any fees or commissions to any broker, finder, or agent with respect to the transactions contemplated by this Agreement.

(v) Shares; Warrants. Seller holds of record and owns beneficially, and good and valid legal title to, the number of Company Common Shares, Company Preferred Shares and Company Warrants set forth next to his, her, or its name in Section 4(b) of the Disclosure Schedule, free and clear of any restrictions on transfer by Seller (other than restrictions under the Securities Act and state securities laws), Taxes, Liens, options, warrants, purchase rights, Contracts, commitments, equities, claims, and demands. Upon the purchase of such equity interests of Seller pursuant to the terms of this Agreement, Buyer will receive good and valid legal title thereto and full beneficial ownership thereof, free and clear of all Liens, Taxes and rights of others of any kind other than those created or permitted by Buyer. Seller is not a party to any option, warrant, purchase right, or other Contract or commitment (other than this Agreement) that could require Seller to sell, transfer, or otherwise dispose of any capital stock or rights to purchase any capital stock of Company. Seller is not a party to any voting trust, proxy, or other agreement or understanding with respect to the voting of any capital stock of Company except a proxy or proxies naming Stockholder Representative as contemplated by this Agreement.

(vi) Certain Business Relationships with Company and Its Subsidiaries. Except for any Seller who has purchased medical professional liability insurance from the Insurance Company in the Ordinary Course of Business, neither Seller nor any of Seller’s Affiliates or family members has been involved in any material business or financial arrangement or relationship with Company or any of its Subsidiaries within the past 12 months other than as a Company Holder, employee, director or officer and neither Seller nor such other Persons owns any material asset, tangible or intangible, that is used in the business of Company or any of its Subsidiaries.  Neither  Seller nor any of Seller’s Affiliates or family members, is directly or indirectly engaged in a business, or owns, manages, operates, controls, finances or participates in the ownership, management, operation, control or financing of, is connected as a principal, owner, partner, shareholder, joint venturer, investor, member, trustee, director, officer, manager, employee, agent, representative or consultant or otherwise with, any Person engaged in a business, involved in any material way with medical professional liability insurance or other products or services competitive with Company or any of its Subsidiaries.

(vii) Information Regarding Transactions.  Seller has received and read a copy of this Agreement and all exhibits and schedules hereto, including but not limited to Section 6(e) below and the Earnout Agreement, and Seller has relied on nothing other than such documents and other information provided by Company and Stockholders Representative in deciding whether to become a Party.  In addition, Seller acknowledges that he , she or it has been given the opportunity to (A) ask questions and receive satisfactory answers from Company and Stockholders Representative concerning the terms and conditions of the transaction contemplated hereby, and (B) obtain additional information in order to evaluate the merits of the transaction contemplated hereby and to verify the accuracy of the information provided to him, her or it by Company and Stockholders Representative in connection with the transaction contemplated hereby.  Seller also acknowledges that

 
25

 

the Earnout Payments (as such term is defined in the Earnout Agreement) are contingent upon the ability of Company to reach certain performance thresholds during the two-year period following Closing and such Earnout Payments may be reduced or eliminated as a result of breaches of Company’s and, with respect to Seller’s portion of such Earnout Payments, Seller’s warranties and covenants contained in this Agreement, to the extent hereinafter set forth in this Agreement and as set forth in the Earnout Agreement.

(b) Buyer's Representations and Warranties.  Buyer represents and warrants to Company and each Seller that the statements contained in this Section 3(b) are correct and complete as of the date of this Agreement, except as set forth in Annex II attached hereto.

(i) Organization of Buyer and Merger Co. Each of FIG, FPIC and Merger Co is a corporation duly organized, validly existing, and in good standing under the Legal Requirements of the jurisdiction of its incorporation.

(ii) Authorization of Transaction. Each of FIG, FPIC and Merger Co has full power and authority (including full corporate or other entity power and authority) to execute and deliver this Agreement and to perform its obligations hereunder. This Agreement constitutes the valid and legally binding obligation of Buyer enforceable in accordance with its terms  except as such enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors’ rights or by general principles of equity. Buyer need not give any notice to, make any filing with, or obtain any authorization, consent, or approval of any Governmental Body or other Person in order to consummate the transactions contemplated by this Agreement. The execution, delivery and performance of this Agreement and all other agreements contemplated hereby have been duly authorized by Buyer.

(iii) Non-contravention. Neither the execution and delivery of this Agreement, nor the consummation of the transactions contemplated hereby, will (A) violate any constitution, statute, regulation, rule, injunction, judgment, order, decree, ruling, charge, or other restriction of any Governmental Body to which Buyer or Merger Co is subject or any provision of its charter, bylaws, or other governing documents or (B) conflict with, result in a breach of, constitute a default under, result in the acceleration of, create in any party the right to accelerate, terminate, modify, or cancel, or require any notice under any Contract or other arrangement to which Buyer or Merger Co is a party or by which it is bound or to which any of its assets is subject.

(iv) Sufficient Funds. Buyer has sufficient funds on hand to pay the Closing Consideration.
 
(v) Brokers' Fees. Other than Buyer’s agreement with Sandler, O’Neill & Partners, L.P., Buyer has no liability or obligation to pay any fees or commissions to any broker, finder, or agent with respect to the transactions contemplated by this Agreement.
 
 

 
26 

 


(vi) Investment and other Securities Representations. Buyer is not acquiring the Shares with a view to or for sale in connection with any distribution thereof within the meaning of the Securities Act.  Buyer is an "accredited investor" as such term is defined in Rule 501 under the Securities Act. Buyer acknowledges that the Shares to be acquired by Buyer pursuant to the transactions contemplated hereby have not been registered under the Securities Act or the securities laws of any state or other jurisdiction and cannot be disposed of unless they are subsequently registered under the Securities Act and the securities laws of any applicable state or other jurisdiction or an exemption from such registration is available.

(vii) No Other Representations.  Buyer acknowledges that, in connection with the transactions contemplated hereby, it is not relying upon any express or implied representations or warranties of any nature, whether in writing, orally or otherwise, made by or on behalf of or imputed to the Company or the Company Holders, except as expressly set forth in this Agreement and in the other documents, instruments and certificates executed in connection with the transactions contemplated hereby. Without limiting the generality of the foregoing, Buyer acknowledges that neither Company nor the Company Holders makes any representation or warranty with respect to (A) any projections, estimates or budgets delivered to or made available to Buyer of revenues,  results of operations (or any component thereof), cash flows or financial condition (or any component thereof) of Company and its Subsidiaries after the Closing or the business and operations of Company and its Subsidiaries after the Closing or (B) any other information or documents made available to Buyer or its counsel, accountants or advisors with respect to Company and its Subsidiaries or any of their respective businesses, assets, liabilities or operations, except as expressly set forth in this Agreement and in the other  documents, instruments and certificates executed in connection with the transactions contemplated hereby.

Section 4.         Representations and Warranties Concerning Company and Its Subsidiaries.  Company represents and warrants to Buyer that the statements contained in this Section 4 are correct and complete as of the date of this Agreement, except as set forth in the disclosure schedule delivered by Company to Buyer on the date hereof  (the "Disclosure Schedule").

(a) Organization, Qualification, and Corporate Power; Authorization of Transaction.  Company and each of its Subsidiaries are corporations duly organized, validly existing, and in good standing under the Legal Requirements of the jurisdiction of their incorporation.  Company and each of its Subsidiaries are duly authorized to conduct business and are in good standing under the Legal Requirements of each jurisdiction where such qualification is required, except where the lack of such qualification would not have a Material Adverse Effect. Company and its Subsidiaries each has full corporate power and authority to execute and deliver this Agreement and the other agreements of Company and its Subsidiaries contemplated hereby, to perform its obligations hereunder and thereunder, to carry on the business in which it is engaged and to own, lease and use the properties and assets owned, or leased, and used by them. Section 4(a) of the Disclosure Schedule identifies the directors and officers of Company and each of its Subsidiaries.  This Agreement constitutes the valid and legally binding obligation of Company,

 
 
27 

 

enforceable in accordance with its terms except as such enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors’ rights or by general principles of equity. Company has delivered to Buyer true and correct copies of the Articles of Incorporation and Bylaws of Company and of each of its Subsidiaries as in effect on June 30, 2009 and, if different in any respect, as in effect on the date hereof.
 
(b) Capitalization.   The entire authorized capital stock of Company consists of One Hundred and Fifty Million (150,000,000) shares, of which One Hundred Million (100,000,000) shares are designated as  Common Stock, par value $0.005 per share, and Fifty Million (50,000,000) shares are designated as Preferred Stock, par value $0.005 per share, of which Six Million (6,000,000) shares have been further designated as shares of Series A Preferred Stock, and Fifteen Million (15,000,000) shares have been further designated as shares of Series B Preferred Stock.   Exactly 4,180,300 shares of such Common Stock, 3,884,999 shares of such Series A Preferred Stock, and 3,634,643 shares of such Series B Preferred Stock are issued and outstanding and Company Warrants to acquire 675,138 Company Common Shares are issued and outstanding, all as of the date of this Agreement.  All of the issued and outstanding Shares have been duly authorized, are validly issued, fully paid, and non-assessable, and are held of record by the respective Company Holders as set forth in Section 4(b) of the Disclosure Schedule. All of the Company Warrants have been duly authorized and are held of record by the respective Company Holders as set forth in Section 4(b) of the Disclosure Schedule.  There are no outstanding or authorized options, warrants, purchase rights, subscription rights, conversion rights, exchange rights, or other Contracts, commitments or rights that could require Company, directly or indirectly, to issue, sell, or otherwise cause to become outstanding any of its capital stock. There are no outstanding or authorized stock appreciation, phantom stock, profit participation, or similar rights with respect to Company.

(c) Non-contravention.   Neither the execution and delivery of this Agreement, nor the consummation of the transactions contemplated hereby, will (i) violate any constitution, statute, regulation, rule, injunction, judgment, order, decree, ruling, charge, or other restriction of any Governmental Body to which Company or any of its Subsidiaries are subject or any provision of the charter or bylaws, or other governing documents, of Company or any of its Subsidiaries or (ii) conflict with, result in a breach of, constitute a default under, result in the acceleration of, create in any party the right to accelerate, terminate, modify, or cancel, or require any notice under any Contract or other arrangement to which Company or any of its Subsidiaries is a party or by which it is bound or to which any of their assets is subject (or result in the imposition of any Lien upon any of their assets).  Except as disclosed on Section 4(c) of the Disclosure Schedule, neither Company nor any of its Subsidiaries needs to give any notice to, make any filing with, or obtain any authorization, consent, or approval of any Governmental Body or other Person in order for the Parties to consummate the transactions contemplated by this Agreement.
(d) Brokers' Fees.  Other than the Company’s agreement with Fox-Pitt, which has been previously disclosed to Buyer, neither Company nor any of its Subsidiaries has any liability or obligation to pay any fees or commissions to any broker, finder, or agent with respect to the transactions contemplated by this Agreement.

 
28

 

 
(e) Title to Tangible Assets.   Company and its Subsidiaries have good and marketable title to, or a valid leasehold interest in, the material tangible assets they use regularly in the conduct of their business.

(f) Subsidiaries.   Section 4(f) of the Disclosure Schedule sets forth for each Subsidiary of Company (i) its name and jurisdiction of incorporation, (ii) the number of authorized shares for each class of its capital stock, (iii) the number of issued and outstanding shares of each class of its capital stock, the names of the holders thereof, and the number of shares held by each such holder, and (iv) the number of shares of its capital stock held in treasury. All of the issued and outstanding shares of capital stock of each Subsidiary of Company have been duly authorized and are validly issued, fully paid, and non-assessable. Company or one of its Subsidiaries holds of record and owns beneficially all of the outstanding shares of each Subsidiary of Company. Except for the Subsidiaries set forth in Section 4(f) of the Disclosure Schedule, neither Company nor any of its Subsidiaries owns or has any right to acquire, directly or indirectly, any outstanding capital stock of, or other equity interests in, any Person.  There are no outstanding or authorized options, warrants, purchase rights, subscription rights, conversion rights, exchange rights, or other Contracts, commitments or rights that could require any Subsidiary of Company, directly or indirectly, to issue, sell, or otherwise cause to become outstanding any of its capital stock. There are no outstanding or authorized stock appreciation, phantom stock, profit participation, or similar rights with respect to any Subsidiary of Company.

(g) Financial Statements.

(i)           Company previously has delivered to Buyer the audited financial statements of Company and its Subsidiaries, on a consolidated basis, as at and for the year ended December 31, 2008 (the “Annual GAAP Financial Statements”) and the unaudited financial statements of Company and its Subsidiaries, on a consolidated basis, as at and for the six months ended June 30, 2009 (the “Most Recent GAAP Financial Statements”). In addition, Company has delivered to Buyer a true and complete copy of the Insurance Subsidiary’s Annual Report for the year ended December 31, 2008, as filed with the Texas Insurance Department (the “Annual Report”) its Quarterly Report for the three months ended March 31, 2009 as filed with the Texas Department of Insurance (the “Quarterly Report”), and the June 30, 2009 internal financial statements of the Insurance Subsidiary (the "June 30, 2009 Internal Financial Statements".  The financial statements contained in the Annual Report are referred to herein as the “Annual Statutory Financial Statements,” the March 31, 2009 financial statements contained in the Quarterly Report,  together with the June 30, 2009 Internal Financial Statements, are referred to herein as the “Most Recent Statutory Financial Statements” and, together with the Most Recent GAAP Financial Statements, as the  “Most Recent Financial Statements” and, together with the Annual GAAP Financial Statements and the financial statements contained in the Annual Report, as the “Financial Statements”.
 
(ii)            The Annual GAAP Financial Statements have been prepared from the books and records of Company and its Subsidiaries and fairly present in all material respects, on a consolidated basis, the financial position, results of operation and the other
 
29

 

 
information contained therein, as at the dates and for the periods indicated therein, in conformity with GAAP, and include all adjustments required for a fair presentation.
 
(iii)           The Most Recent GAAP Financial Statements have been prepared from the books and records of Company and its Subsidiaries and fairly present in all material respects, on a consolidated basis, financial position, results of operations and the other information contained therein, as at the dates and for the periods indicated therein, in conformity with GAAP, subject to normal period-end adjustments and lack of footnotes and other presentation items.

(iv)           The Annual Report and the Quarterly Report have been prepared from the books and records of the Insurance Subsidiary, are materially correct and complete and comply with applicable Legal Requirements.  The financial statements contained therein are fairly presented in conformity with statutory accounting principles. No material deficiency has been asserted with respect to any of the information contained in the Annual Report or the Quarterly Report by the Texas Department of Insurance or any other Governmental Body.  Company has delivered to Buyer copies of all material correspondence sent or received since January 1, 2008, between Company or any of its Subsidiaries and the Texas Department of Insurance or other Governmental Body.  The reserves established and reflected in the Company Financial Statements were determined by the Company Actuary in accordance with generally accepted actuarial standards consistently applied, and to Company's Knowledge are fairly stated in all material respects in accordance with sound actuarial principles and are in compliance in all material respects with the requirements of applicable insurance laws, rules and regulations in the State of Texas as well as those of any other applicable jurisdictions.

(v)           The June 30, 2009 Internal Financial Statements  have been prepared from the books and records of the Insurance Subsidiary in accordance with statutory accounting principles, but are subject to normal period-end adjustments and lack of footnotes and other presentation items.

(vi)           Transaction Expenses incurred through June 30, 2009 were not more than $120,000, all which has been charged as an expense in the Financial Statements.

(vii)           To Company's Knowledge, neither the Company nor any of its Subsidiaries has any material liabilities, obligations or commitments of any nature, whether known or unknown, absolute, accrued, contingent or otherwise and whether due or to become due, that are not disclosed in the Financial Statements, except those incurred in the Ordinary Course of Business since June 30, 2009.
 
(h) Legal Compliance.  Company and each of its Subsidiaries have complied with the provisions of their Articles of Incorporation and bylaws and all applicable Legal Requirements in all material respects. Company and its Subsidiaries each has and is in compliance with all Governmental Body licenses and other authorizations required under all applicable Legal Requirements for it to conduct its business as presently conducted.
 
 
30

 


(i) Tax Matters.

(i) Company and each of its Subsidiaries have filed, or has received from the applicable taxing authority an extension of time in which to file, all Tax Returns that they were required to file, and have paid all Taxes shown thereon as owing.

(ii) No Tax Returns have been audited, and the Company has not received any notice of an audit.  Additionally, to Company's Knowledge, Company has fully and properly disclosed in its Income Tax Returns and in Section 4(i)(ii) of the Disclosure Schedule any uncertain tax positions in the Financial Statements.

(iii) Neither Company nor any of its Subsidiaries has waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect to an Income Tax assessment or deficiency.

(iv) Neither Company nor any of its Subsidiaries is a party to any Income Tax allocation or sharing agreement.

 (v) Neither Company nor any of its Subsidiaries has been a member of an Affiliated Group filing a consolidated federal Income Tax Return (other than a group the common parent of which was Company).

(j) Real Property. 

(i)  Neither Company nor any of its Subsidiaries owns or has ever owned in fee any interest in real property.

 (ii) Section 4(j)(ii) of the Disclosure Schedule sets forth the address of each parcel of Leased Real Property, and a true and complete list of all Leases for each such parcel of Leased Real Property. Company has delivered to Buyer a true and complete copy of each such Lease document.  Company and its Subsidiaries has the legal right to possess and quietly enjoy the real property subject to such Leases and has received no notice from any Person asserting any claim or right inconsistent therewith.

(k) Intellectual Property. 
 
       (i)           The Intellectual Property Assets are all those necessary for the operations of Company and its Subsidiaries and their businesses as currently conducted.

 (ii)           Either Company or one of its Subsidiaries is the owner or licensee of all right, title and interest in and to each of the Intellectual Property Assets, free and clear of all Liens, and has the right to use without payment to any other Person all of the Intellectual Property Assets.

 (iii)           Section 4(k) of the Disclosure Schedule contains a complete and accurate list and summary description of all patents held by the Company or any of its 

 
 
31

 

Subsidiaries and all pending patent applications filed by Company or any of its Subsidiaries.  All of such issued patents are currently in compliance with formal Legal Requirements (including payment of filing, examination and maintenance fees and proofs of working or use), are valid and enforceable, and are not subject to any maintenance fees or taxes or actions falling due within six months after the date hereof.  No such patent or patent application has been or is now involved in any interference, reissue, reexamination, or opposition proceeding.  To the Knowledge of Company, there is no potentially interfering patent or patent application of any other Person with respect to any patent or patent application.

 (iv)           Section 4(k) of the Disclosure Schedule contains a complete and accurate list and summary description of all Marks.  All Marks have been registered with the United States Patent and Trademark Office, are currently in compliance with all formal Legal Requirements (including the timely post-registration filing of affidavits of use and incontestability and renewal applications), are valid and enforceable and are not subject to any maintenance fees or taxes or actions falling due within six months after the date hereof.  No Mark has been or is now involved in any opposition, invalidation or cancellation Proceeding and, to the Knowledge of Company, no such action is threatened with respect to any of the Marks.  To the Knowledge of Company, there is no potentially interfering trademark or trademark application of any other Person.  No Mark is infringed or, to the Knowledge of Company, has been challenged or threatened in any way.  None of the Marks as used by the Company and its Subsidiaries infringes or is alleged to infringe any trade name, trademark or service mark of any other Person.

(v)           Section 4(k) of the Disclosure Schedule contains a complete and accurate list and summary description of all registered Copyrights.  All of the registered Copyrights are currently in compliance with formal Legal Requirements, are valid and enforceable, and are not subject to any maintenance fees or taxes or actions falling due within six months after the date hereof.   No Copyright is infringed or, to the Knowledge of Company, has been challenged or threatened in any way.  None of the subject matter of any of the Copyrights infringes or is alleged to infringe any copyright of any other Person or is a derivative work based upon the work of any other Person.  All works encompassed by the Copyrights have been marked with the proper copyright notice.

(vi)           Section 4(k) of the Disclosure Schedule contains a complete and accurate list and summary description of all Net Names.  All Net Names have been registered in the name of Company or one of its Subsidiaries and are in compliance with all formal Legal Requirements.  No Net Name has been or is now involved in any dispute, opposition, invalidation or cancellation proceeding and, to the Knowledge of Company, no such action is threatened with respect to any Net Name.  To the Knowledge of Company, there is no domain name application pending of any other Person that would or would potentially interfere with or infringe any Net Name.  No Net Name is infringed or, to the Knowledge of Company, has been challenged, interfered with or threatened in any way.  No Net Name infringes, interferes with or is alleged to interfere with or infringe the trademark, copyright or domain name of any other Person.

 
32

 

 
 (l) Contracts.   Except in respect of the Contracts listed in Section 4(l) of the Disclosure Schedule, Contracts entered into in the Ordinary Course of Business, the performance of which involves aggregate consideration of less than $20,000, Leases listed in Section 4(j)(ii) of the Disclosure Schedule and insurance arrangements listed in Section 4(m) of the Disclosure Schedule, none of Company, any of its Subsidiaries or any of their assets or rights is a party to or bound by any Contract.  To the Knowledge of Company, each Contract listed is in full force and effect and is legal, valid and binding and enforceable against each other party thereto, except as may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors' rights or by general principles of equity.  Except as set forth in such Sections of the Disclosure Schedule, neither Company, any of its Subsidiaries Group nor, to the Knowledge of Company, any other party to any such Contract is in material breach thereof or material default thereunder and there does not exist under any provision thereof any event that, with the giving of notice or the lapse of time or both, would constitute such a material breach or material default by Company, any of its Subsidiaries  or, to the Knowledge of Company, any other party to any such Contract. Except as set forth in such Sections of the Disclosure Schedule, Company has delivered or made available to Buyer true, correct and complete copies of each of such written Contracts and provided summaries of any such oral Contracts. Except as set forth in Section 4(l) and Section 4(o)(vi) of the Disclosure Schedule, neither Company nor any of its Subsidiaries is a party to any Contract that contains a “change in control,” “potential change in control” or similar provision, that, as a result of the consummation of the transactions contemplated hereby will (either alone or upon the occurrence of any additional acts or events) result in any payment (whether severance pay or otherwise) becoming due from Company or any of its Subsidiaries to any Person, or the acceleration, termination or modification of any obligations, rights, or contracts under such Contract.

(m) Insurance.   Company and its Subsidiaries maintain insurance policies and reinsurance policies with insurers and reinsurers, in such amounts and against such risks of Company and its Subsidiaries as are customary and reasonable for the business, rights and the assets of Company and its Subsidiaries. Company and its Subsidiaries maintain all policies that it is required to have under the provisions of any Lease or other Contract to which such Person is a party.  Section 4(m) of the Disclosure Schedule lists and describes briefly all policies of liability, theft, fire, title, workers' compensation, reinsurance and other forms of insurance and surety bonds insuring Company, any of its Subsidiaries or the employees, properties, assets and business of Company and its Subsidiaries. All policies listed in Section 4(m) of the Disclosure Schedule are in full force and effect; no such policy or the future proceeds thereof has been assigned to any other Person; and all premiums and other payments due under or on account of any such policy have been paid.
(n) Litigation.   Section 4(n) of the Disclosure Schedule sets forth each instance in which Company or any of its Subsidiaries, or any of their properties, assets, rights or operations, (i) is subject to any outstanding injunction, judgment, order, decree, ruling, or charge or (ii) is a party or specifically subject to any action, suit, proceeding, hearing, or investigation of, in, or before any court or quasi-judicial or administrative agency of any Governmental Body.  Except as set forth in Section 4(n) of the Disclosure Schedule, the full effect on Company and its Subsidiaries, and on any of their properties, assets, rights or operations, of any such injunction, judgment, order, decree, ruling, action, suit, proceeding, hearing, or investigation is fully reserved for in the

 
 
33 

 

Most Recent Financial Statements.  To the Knowledge of Company, (i) no action, suit, proceeding, hearing, or investigation of the nature or relating to the matters described in the preceding sentence has been threatened which, in the event of an adverse outcome, would be reasonably expected to materially exceed the amounts reserved by Company on its Most Recent Financial Statements or have a Material Adverse Effect, and (ii) there is no basis for any action, suit, proceeding, hearing, or investigation of such nature or relating to such matters which, in the event of an adverse outcome, would be reasonably expected to result in a material charge to the consolidated earnings of Company and its Subsidiaries or have a Material Adverse Effect.

(o) Employee and Employee Benefit Matters. 

(i)           Section 4(o)(i) of the Disclosure Schedule contains a true and complete list of (A) each plan, program, policy, payroll practice, Contract or other arrangement providing for compensation, severance, termination pay, performance awards, equity or equity-related awards, fringe benefits or other employee pension or welfare benefits of any kind, whether formal or informal or funded or unfunded, that is now sponsored, maintained, contributed to or required to be contributed to, by Company or any of its Subsidiaries or pursuant to which Company or any of its Subsidiaries has, or could reasonably be expected to have, any liability, including, without limitation, any "employee benefit plan" within the meaning of Section 3(3) of ERISA (each a "Company Group Benefit Plan"); and (B) each management, employment, bonus, option, equity (or equity related), severance, consulting, non-compete, confidentiality or similar Contract currently in effect between Company or any of its Subsidiaries and any current, former or retired employee, officer, consultant, independent contractor, agent, member or partner of Company or any of its Subsidiaries (each a "Company Group Employee Agreement"). Neither the Company nor any of its Subsidiaries currently sponsors, maintains, contributes to, or is it required to contribute to, nor has Company or any of its Subsidiaries ever sponsored, maintained, contributed to or been required to contribute to, or incurred any liability to, (C) any "defined benefit plan" (as defined in ERISA Section 3(35)), (D) any "multiemployer plan" (as defined in ERISA Section 3(37)) or any plan that has two or more contributing sponsors at least two of whom are not under common control (within the meaning of Section 4063 of ERISA), (E) except as set forth on Section 4(o)(i) of the Disclosure Schedule, any plan that is, is intended to be, or has ever been treated as a "qualified plan" (within the meaning of Section 401(a) of the Code) or any plan that is, is intended to be, or has ever been treated as a plan subject to Title IV of ERISA, or (F) any Company Group Benefit Plan or Company Group Employee Agreement that provides, or has any liability to provide, life insurance, medical, severance or other employee welfare benefits to any employee (or Affiliate or family member thereof) upon or following the employee's retirement or termination of employment, except as required by Section 4980B of the Code or Part 6 of Title I of ERISA.
(ii)           Neither Company nor any of its Subsidiaries is or has never been (A) a member of a" controlled group of companies," under "common control" or an "affiliated service group" within the meaning of Sections 414(b), (c) or (m) of the Code,(B) required to be aggregated under Section 414(o) of the Code, or (C) under "common control,"

 
34

 

 
within the meaning of Section 4001(a)(14) of ERISA, or any regulations promulgated or proposed under any of the foregoing sections, in each case with any other entity other than Company and its Subsidiaries.
 
(iii)           Company has provided to Buyer accurate and complete copies of all documents embodying or relating to each Company Group Benefit Plan and each Company Group Employee Agreement, including all amendments thereto, trust or funding agreements relating thereto, the two most recent annual reports required under ERISA, the most recent determination letter received from the Internal Revenue Service, if any, and the most recent summary plan description (with all material modifications).

(iv)           All contributions required to be made to or with respect to any Company Group Benefit Plan or Company Group Employee Agreement by applicable Legal Requirements or by any plan document or other contractual undertaking, and all premiums due or payable with respect to insurance policies funding any Company Group Benefit Plan or Company Group Employee Agreement, for any period through the Closing Date have been or, as applicable, will be, timely made or paid in full or, to the extent not required to be made or paid on or before the Closing Date, will be fully disclosed on Section 4(o)(iv) of the Disclosure Schedule.

(v)           Each Company Group Benefit Plan and each Company Group Employee Agreement is currently, and has been and will be at all times prior to the Closing Date, maintained substantially in accordance with its terms and in compliance in all material respects with all applicable Legal Requirements, including, without limitation, ERISA and the Code. There is not now nor, to the Knowledge of Company, do any circumstances exist that could reasonably be expected to give rise to, any requirement for the posting of security with respect to a Company Group Benefit Plan or Company Group Employee Agreement or the imposition of any Lien on any assets or rights of Company or any of its Subsidiaries under applicable Legal Requirements, including, without limitation, ERISA and the Code.

(vi)           Except as set forth on Section 4(o)(vi) of the Disclosure Schedule, the execution and performance of the transactions contemplated by this Agreement will not (either alone or upon the occurrence of any additional or subsequent events directly related to the transactions contemplated by this Agreement) constitute an event under any Company Group Benefit Plan or Company Group Employee Agreement that will or may result in any payment, acceleration, forgiveness of indebtedness, vesting, distribution, increase in benefits or obligations to fund benefits with respect to any employee or former employee or any spouse or dependent thereof.
 
(vii)           (A) Neither Company nor any of its Subsidiaries is delinquent in payments to any of its employees for any wages, salaries, commissions, bonuses or other direct compensation for any services performed by the date hereof or amounts required to be reimbursed by them to the date hereof, (B) Company and each of its Subsidiaries is in material compliance with all applicable Legal Requirements respecting employment, employment practices, employment safety, labor, terms and conditions of employment

 
 
35 

 


and wages and hours, (C) neither Company nor any of its Subsidiaries is bound by or subject to (and none of its assets or rights is bound by or subject to) any written or oral, express or implied, commitment or arrangement with any labor union, and no labor union has requested or has sought to represent any of the employees of Company or any of its Subsidiaries, (D) there is no labor strike, dispute, slowdown or stoppage actually pending, or, to the Knowledge of Company, threatened, against or involving the Company or any of its Subsidiaries, and (E) to the Knowledge of Company, no salaried employee has any plans to terminate his or her employment with Company or any of its Subsidiaries during 2009.
 
(viii)           For purposes of this Section 4(o), the term "employee" will be considered to include individuals rendering personal services to Company or any of its Subsidiaries as independent contractors.

(ix)           Section 4(o)(ix) of the Disclosure Schedule contains a true, correct and complete list of the name of each individual who is an employee of Company or any of its Subsidiaries on the date hereof along with his or her current job title, base compensation, eligibility for bonus compensation or any other compensation, date of hire, last date and amount of increase in compensation, any employee benefit that is not generally available to employees of Company and its Subsidiaries and employment address. Section 4(o)(ix) of the Disclosure Schedule contains a true, correct and complete list of individuals currently rendering services to Company or any of its Subsidiaries for which Company or one of its Subsidiaries is obligated to issue a Form 1099, as consultants or independent contractors, along with information regarding compensation and reimbursement levels for each such individual during all such periods.  Each Person who was classified as a consultant or an independent contractor at any time by Company or any of its Subsidiaries was properly so classified under applicable Legal Requirements, has been provided a Form 1099 if such form was due prior to the date hereof and no Taxes should have been withheld from any payment made to any such Person that were not withheld.

(x)           Except as set forth on Section 4(o)(x) of the Disclosure Schedule, with respect to each Company Group Benefit Plan and Company Group Employee Agreement, there have been no "prohibited transactions" (within the meaning of Section 406 of ERISA and Section 4975 of the Code) and no fiduciary with respect to any Company Group Benefit Plan or Company Group Employee Agreement has incurred or, to the Knowledge of Company, can reasonably be expected to incur, liability for a breach of fiduciary duty or other failure to act or comply in connection with the administration or investment of the assets of any Company Group Benefit Plan. Further, no action, suit, proceeding, or hearing or, to the Knowledge of Company, investigation with respect to any Company Group Benefit Plan or Company Group Employee Agreement is pending or, to the Knowledge of Company, threatened.  Company has no Knowledge of any existing circumstances that could reasonably be expected to give rise to any action, suit, proceeding, hearing, or investigation involving a Company Group Benefit Plan or Company Group Employee Agreement.

 
36 

 

 
(p) Bank Accounts.  Company has delivered to Buyer a true, correct and complete list of each bank and other financial institution at which Company or any Subsidiary has an account (including a securities custodial or investment account) or safe deposit box and the address of each such bank and other institution, the number of such account or box and the name of each individual authorized to draw on or have access thereto.

(q) Information Technology.  Section 4(q) of the Disclosure Schedule sets forth a list and brief description of all material computer hardware and Software used by Company or any of its Subsidiaries and identifies which are owned by Company or one of its Subsidiaries directly and which are licensed to Company or one of its Subsidiaries for use. Company and each of its Subsidiaries have the unrestricted right to use all Software associated with its respective databases.

(r)  Board Recommendation.  The Board of Directors of Company, at a meeting duly called and held, has by vote of those directors present (who constituted all of the directors then in office) (A) determined that this Agreement and the transactions contemplated hereby, including the Stock Purchase and the Merger, taken together, are in the best interests of the Company Holders, based upon input the Board of Directors of Company has received from Fox Pitt and various other factors, and (B) resolved to recommend that the Company Holders of Shares approve this Agreement and such transactions and to sell their interests in Company to Buyer on the terms and conditions hereof.

(s) Vote Required.  The only votes or approvals of Company Holders necessary to approve the Merger by written consent without a meeting is the affirmative written consent of the Company Holders of at least two thirds of the issued and outstanding Shares, provided such affirmative written consents include the Company Holders of at least a majority of the outstanding shares of each class of Company Preferred Stock. The only votes or approvals of Company Holders necessary to approve the Merger at a meeting of holders of Shares is the affirmative vote of at least a majority of the issued and outstanding Shares, provided such affirmative votes include the vote of at least a majority of the outstanding shares of each class of Company Preferred Stock.

(t) Absence of Sensitive Payments.  To the Knowledge of Company, none of Company, any of its Subsidiaries or Affiliates or any officer or director of any of them, acting alone or together, has performed any of the following acts:  (A) the making of any contribution, payment, remuneration, gift or other form of economic benefit to or for the private use of any governmental official, employee or agent where such economic benefit or the purpose of such economic benefit was illegal under the laws of the United States or the jurisdiction in which such payment was made, or (B) the establishment or maintenance of any unrecorded fund, asset or liability for any purpose or the making of any false or artificial entries on its books.
(u) Books and Records.  The books of account, minute books, stock record books and other records of Company and each of its Subsidiaries, all of which have been made available to Buyer, are complete and correct and have been maintained in accordance with sound business practices.  The minute books of Company and each of its Subsidiaries contain accurate and complete records of all meetings held of, and corporate action taken by its stockholders and its

 
 
37 

 


Board of Directors, and no meeting of any such stockholders or Board of Directors has been held for which minutes have not been prepared and are not contained in such minute books.  No material corporate action has been taken by any committee of the Board of Directors other than actions that have been ratified or otherwise approved by the Board of Directors and reflected in the minutes of meetings of the Board of Directors.  At the Closing all of those books and records will be in the possession of Company and its Subsidiaries.

(v) Certain Business Relationships with Company and Its Subsidiaries.   To Company’s Knowledge, none of Company’s or its Subsidiaries’ directors or officers, or their Affiliates or immediate family members, (i) has been involved in any material business or financial arrangement or relationship with Company or any of its Subsidiaries within the past 12 months other than as a Company Holder, employee, director or officer, (ii) owns any material asset, tangible or intangible, that is used in the business of Company or any of its Subsidiaries (iii) is directly or indirectly engaged in a business, or owns, manages, operates, controls, finances or participates in the ownership, management, operation, control or financing of, is connected as a principal, owner, partner, shareholder, joint venturer, investor, member, trustee, director, officer, manager, employee, agent, representative or consultant or otherwise with, any Person engaged in a business, involved in any material way with the administration, development, provision, operation, management, marketing or  sale of medical professional liability insurance or other products or services competitive with Company or any of its Subsidiaries in the State of Mississippi or the State of Texas.

(w) Absence of Certain Developments or Changes.  To Company’s Knowledge, there has not occurred any event or development that could reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on the Company and its Subsidiaries, taken as a whole.  Since December 31, 2008, except as reflected in the Most Recent Financial Statements, Company and its Subsidiaries have conducted their activities and operation in the Ordinary Course of Business and maintained its books and records in reasonable detail that accurately and fairly reflect the transactions of Company and its Subsidiaries in all material respects. Since December 31, 2008, except as set forth in the Most Recent Financial Statements or as otherwise expressly contemplated by this Agreement, there has not been:
 
(i)           any declaration, setting aside or payment of distributions in respect of any of the Shares;

(ii)           any entering into of any Company Group Employee Agreement, or any increase in the compensation payable, or to become payable, by Company or any of its Subsidiaries to any of its directors, officers, employees or agents over the rates payable at December 31, 2008;

(iii)           any issuance of securities of Company or any of its Subsidiaries, including options, warrants or other Contracts evidencing or requiring such issuance;

(iv)           any amendment or termination (other than in the Ordinary Course of Business) of, default by Company or any of its Subsidiaries or, to the Knowledge of

 
38

 

Company, default by any other party under, any material Contract to which Company or any of its Subsidiaries is a party;
 
(v)           any discharge or satisfaction of any Lien or liability of Company or any of its Subsidiaries except in the Ordinary Course of Business with respect to current liabilities and insurance policy liabilities;

(vi)           any incurrence by Company or any of its Subsidiaries of any liability except current liabilities and insurance policy  liabilities incurred, and obligations (other than in respect of indebtedness) entered into, in the Ordinary Course of Business;

(vii)           any institution of any Company Group Benefit Plan or Company Group Employee Agreement or any changes made in any Company Group Benefit Plan or Company Employee Agreement;

(viii)           any capital expenditure;

(ix)           any announcement or initiation of any general increase in compensation, bonus, insurance or employee benefits involving employees or directors of Company or any of its Subsidiaries;

(x)           any sale, disposition or lease of any assets of Company or any of its Subsidiaries except in the Ordinary Course of Business or any mortgage, pledge, or grant or imposition of any Lien on any asset or property of Company or any of its Subsidiaries;

(xi)           any cancellation or waiver of any material claims or rights of Company or any of its Subsidiaries;

(xii)           any amendment to the Articles of Incorporation or bylaws of  Company or any of its Subsidiaries, or of any Company Preferred Stock Certificate of Designation; or
 
(xiii)           any change in GAAP or statutory accounting practices by Company or any of its Subsidiaries outside the Ordinary Course of Business or inconsistent with Company’s representations and warranties set forth in this Section 4.
 
(x) Relationship with Customers.  Section 4(x) of the Disclosure Schedule lists each policyholder customer of the Insurance Subsidiary that has represented in excess of five (5%) percent of the Insurance Subsidiary's revenues from policyholder customers in the calendar year ended December 31, 2008 or in the six month period ended June 30, 2009, or which in the good faith judgment of Company is expected to account for in excess of five (5%) percent of the such revenues in the calendar year ending December 31, 2009.  No such policyholder customer has terminated its relationship with the Insurance Subsidiary or significantly reduced the volume of business conducted by it with the Insurance Subsidiary. Except as described in Section 4(x) of the Disclosure Schedule, Company has no Knowledge that any significant policyholder customer of the Insurance Subsidiary, (A) has made any material complaint or objection with respect to the service or any business practices of the Insurance Subsidiary or the transactions contemplated

 
 
39

 

hereby or (B) will cease to do business, or significantly reduce the business conducted, with the Insurance Subsidiary after or as a result of the consummation of any transactions contemplated hereby.

(y) Communications with Company Holders. With respect to the transactions contemplated hereby, Company has provided, or will provide, to the Company Holders true and correct copies of the following documents: (i) this Agreement, (ii) the Earnout Agreement, (iii) the Proxy Statement, (iv) the Joinder Agreement, and (v) such other documents and information as Company believes necessary or appropriate.  All such information contained in the Proxy Statement is or will be correct and complete in all material respects, and such information does not, or will not, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.

Section 5.          Pre-Closing Covenants.  The Parties agree as follows with respect to the period between the execution of this Agreement and the Closing.

(a) General.   Each of the Parties will use his, her, or commercially reasonable efforts to take all actions and to do all things necessary in order to consummate and make effective the transactions contemplated by this Agreement (including satisfaction, but not waiver, of the Closing conditions set forth in Section 7 below).

(b) Notices and Consents; Closing Reserve Study.   Company will give any notices to third parties, and use commercially reasonable efforts to obtain any third party consents (including but not limited to the consent and approval of Company Holders to the Merger and other transactions contemplated hereby), referred to in Section 4(c) above. Each of the Parties will give any notices to, make any filings with, and use commercially reasonable efforts to obtain any authorizations, consents, and approvals of governments and governmental agencies in connection with the matters referred to in Section 3(a)(ii), Section 3(b)(ii) and Section 4(c) above.  In furtherance thereof, Buyer agrees to file its Form A application with the Texas Department of Insurance as promptly as practicable and will use commercially reasonable efforts to make its initial filing by August 15, 2009 (or at the earliest practicable date thereafter when a conference can be arranged with representatives of the Texas Insurance Department) and to promptly respond to requests of the Texas Department of Insurance.  Company will obtain the Closing Reserve Study from Company Actuary and deliver a copy thereof to Buyer.
(c) Operation of Business.   Except as otherwise expressly provided in this Agreement or as agreed in writing by Buyer prior to taking such action (which written agreement shall not be unreasonably withheld, conditioned or delayed), between the date of this Agreement and the Closing Date, the Company will not, and will cause its Subsidiaries not to, engage in any practice, take any action, or enter into any transaction outside the Ordinary Course of Business.  Except as otherwise expressly contemplated by this Agreement, between the date of this Agreement and the Closing Date, Company will not terminate or amend the amended and restated Executive Employment Agreement with Mark A. Adams or the Non-Competition Agreement with Buyer and Mark A. Adams being entered into contemporaneously with this Agreement and Company will, and will cause and each of its Subsidiaries to, use its and their

 
 
40

 
 
 
commercially reasonable efforts to preserve intact the current business organization of Company and each of its Subsidiaries, keep available the services of the current officers, employees and agents of Company and each of its Subsidiaries and maintain good relations and goodwill with customers, landlords, creditors, employees, agents and others having business relationships with Company or any  of its Subsidiaries.  Between the date hereof and the Closing Date, except as otherwise expressly provided in this Agreement, without the prior consent of Buyer, (i) Company will not, and will permit any of its Subsidiaries to, take any affirmative action, or fail to take any reasonable action within each such respective Person’s control, in each case that would reasonably be expected to result in the occurrence of any of the changes or events listed in Section 4(w) above or inaccuracy or breach of any of the representations and warranties set forth in  Section 4 above, and (ii) none of the Sellers will take any affirmative action, or fail to take any reasonable action within each such respective Seller’s control, in each case that would reasonably be expected to result in the occurrence of any inaccuracy or breach of any of the representations and warranties set forth in  Section 3(a) above.

 
(d) Full Access.   Company will, and will cause each of its Subsidiaries to, permit, representatives of Buyer (including legal counsel and accountants) to have full access at all reasonable times, and in a manner so as not to interfere with the normal business operations of Company and its Subsidiaries, to all premises, properties, personnel, books, records (including tax records), Contracts, and documents of or pertaining to Company and each of its Subsidiaries.  Buyer will treat and hold as such any Confidential Information it receives from any of Sellers, Company, and its Subsidiaries in the course of the reviews contemplated by this Section 5(d) as provided in the Confidentiality Agreement.

(e) Notice of Developments.

(i) From time to time before the Closing, the Company may supplement the Disclosure Schedules to disclose any matter hereafter arising that, if existing or occurring at or before the date of this Agreement, would have been required to be set forth or described in the Disclosure Schedule, or that is necessary to correct any information in the Disclosure Schedule that has become inaccurate after the date hereof. For avoidance of doubt, the Company may only supplement the Disclosure Schedules to reflect matters arising after the date of this Agreement.
(ii) From time to time before the Closing, each Seller may supplement Annex I to disclose any matter hereafter arising that, if existing or occurring at or before the date of this Agreement, would have been required to be set forth or described in Annex I with respect to such Seller, or that is necessary to correct any information in Annex I that has become inaccurate after the date hereof. For avoidance of doubt, a Seller may only supplement Annex I to reflect matters arising after the date of this Agreement.

(iii) If any such supplements are provided to Buyer, Company may, in its sole discretion, deliver to Buyer written authorization to terminate this Agreement as a result of the matters set forth in such supplements as are designated by Company in such authorization.  If such authorization is given, Buyer may, by written notice to Company delivered prior to Closing terminate this Agreement, which termination shall be deemed

 
 
41

 
 
 
to be as a result of a failure of a condition in Section 7(a) or incorporated by reference in Section 7(d).  If Buyer does not elect to terminate this Agreement as a result of such authorization and the Closing nevertheless occurs, then notwithstanding anything to the contrary in this Agreement, Buyer shall not be entitled to indemnification or any other remedies in respect of such matter or matters set forth in such designated supplements.
 
 (iv) If any such supplements are provided to Buyer and Company does not authorize Buyer to terminate this Agreement pursuant to Section 5(e)(iii) above with respect to any such supplements, and the Closing occurs, such supplements shall not affect the rights of Buyer to indemnification, or any other remedy, with respect to such matter or matters after the Closing to the extent provided in this Agreement.

(v) Nothing contained in this Section 5 will affect the rights of Buyer to indemnification, or any other remedy, to the extent provided in this Agreement for any matter or matters not permitted to be the subject of a supplement under the terms of Section 5(i) or Section 5(ii) above.

(vi) Buyer will give prompt notice to Company and Stockholders Representative of any breach of or inaccuracy in any representation or warranty of Company or any Seller promptly after becoming Known to Buyer other than any such breach or inaccuracy that is or could be the subject of a notice by another Party under the provisions of this Section 5. Such notice shall be deemed not to constitute a supplement provided by Company or a Seller pursuant to Section 5(e)(i) or Section (ii) above.

 (f) Exclusivity.   Company will not, and will not authorize or permit any of its Subsidiaries or any other Person acting on its behalf to, directly or indirectly, solicit, initiate, or encourage the submission of any proposal or offer from any Person relating to the acquisition of capital stock or assets of Company or any of its Subsidiaries (including any acquisition structured as a merger, consolidation, or share exchange), including by way of furnishing information, cooperating  or taking any other action to facilitate any enquiries or the making of any proposal that constitutes or may reasonably be expected to lead to an acquisition proposal for capital stock or assets of Company or any of its Subsidiaries. In the event that any Company or any of its Subsidiaries receives an unsolicited offer for such a transaction or obtains information that such an offer is likely to be made, Company will provide Buyer with notice thereof as soon as practical, including the identity of the prospective purchaser or soliciting party.
(g) Payments under Company 2009 Bonus Program.  In the event the Closing occurs at or prior to the date at which Company’s annual employee bonuses would otherwise normally become payable, Buyer agrees that Company may pay bonuses to Company employees, officers and directors at or prior to Closing: (i) to the extent such bonuses payable do not exceed the respective bonus amounts stated in information provided by Company to Buyer prior to the date hereof, and (ii) so long as a schedule of bonuses to be paid is provided to Buyer in advance for its review.

(h) Second Quarter Report.  Company will file with the Texas Insurance Department on or before its due date, and promptly provide a copy to Buyer of, Insurance Subsidiary’s

 
42

 
 
Quarterly Report for the three months ended June 30, 2009, which Quarterly will Report will contain information not materially inconsistent with the information contained in the June 30, 2009 Internal Financial Statements.
 
(i) Certain Employee Agreements.  Buyer will offer to enter into, or to cause the Company to enter into, agreements, that will become effective as of the Closing, with Thomas Smith and Steve Loranger, substantially on the terms previously discussed between Buyer and Stockholders Representative.

Section 6.         Post-Closing Covenants.   The Parties agree as follows with respect to the period following the Closing.

(a) General.   In case at any time after the Closing any further action is necessary to carry out the purposes of this Agreement, Buyer and Stockholders Representative will take such further action (including the execution and delivery of such further instruments and documents) as the other Party reasonably may request, all at the sole cost and expense of the requesting Party (unless the requesting Party is entitled to indemnification therefor under Section 8 below).

(b) Litigation Support.   In the event and for so long as any Party actively is contesting or defending against any action, suit, proceeding, hearing, investigation, charge, complaint, claim, or demand in connection with (i) any transaction contemplated under this Agreement or (ii) any fact, situation, circumstance, status, condition, activity, practice, plan, occurrence, event, incident, action, failure to act, or transaction on or prior to the Closing Date involving Company or any of its Subsidiaries, each of the other Parties will cooperate with him, her, or it and his, her, or its counsel in the defense or contest, make available his, her, or its personnel, and provide such testimony and access to his, her, or its books and records as will be necessary in connection with the defense or contest, all at the sole cost and expense of the contesting or defending Party (unless the contesting or defending Party is entitled to indemnification therefor under Section 8 below).
 
(c) Transition.   No Stockholders Representative will take any action that is designed or intended to have the effect of discouraging any lessor, licensor, customer, supplier, or other business associate of Company or any of its Subsidiaries from maintaining the same business relationships with Company and its Subsidiaries after the Closing as it maintained with Company and its Subsidiaries prior to the Closing.

(d) Officers’ and Directors’ Indemnification.   The Company,  the Sellers and Buyer agree that all rights to exculpation, indemnification, defense and advancement of expenses existing in favor of, and all limitations on the personal liability of, the directors, officers, employees of the Company and its Subsidiaries ("Indemnified Persons") provided for in  the Articles of Incorporation or bylaws of the Company or its Subsidiaries, as applicable, as in effect as of June 30, 2009, or in any organizational documents or Contracts identified in Section 6(d) of the Disclosure Schedule (provided Company has provided Buyer with a true and correct copy thereof prior to the date hereof) with respect to  (to the extent provided in such Articles of Incorporation, bylaws, organizational documents or Contracts) all claims,  losses, liabilities, damages, judgments, inquiries, fines and reasonable fees, costs and expenses, including

 
 
43 

 


attorneys' fees and disbursements incurred in connection with any claim, action, suit, proceeding or  investigation, whether civil, criminal, administrative or investigative, arising  out of actions or omissions by them in their capacity as directors, officers or employees prior to and through the Closing, and (to the extent provided in such Articles of Incorporation, bylaws, organizational documents or Contracts) specifically including the transactions contemplated hereby, will continue in full force and effect for a period of six (6) years from the Closing; provided, however, that all rights to indemnification in respect of any claims asserted or made within such period will continue until the disposition of such claim. Following the Closing, Buyer will not, and will not permit Company or any Subsidiary to, amend or modify its  Articles of Incorporation or bylaws or other organizational documents, as applicable, except as required by applicable Legal Requirements, if the effect of such amendment or modification would be to lessen or otherwise adversely affect the exculpation of, or rights to indemnification,  defense or advancement of expenses of, such Indemnified Persons as provided therein, and Buyer will cause Company or any Subsidiary to advance, from its own resources, expenses to each such Indemnified  Person in connection with any proceeding involving such Indemnified Person to the fullest extent so permitted by the provisions of such Articles of Incorporation, bylaws, other organizational documents or Contracts upon receipt of any undertaking required by applicable Legal Requirements or in the Articles of Incorporation, bylaws, other organizational documents or contracts of Company or such Subsidiary, as applicable. In the event that Company or any Subsidiary transfers all or substantially all of its properties and assets to any Person, then and in each such case, proper provision will be made so that the transferee of such properties or assets will assume the obligations of Company or such Subsidiary, as applicable, under this Section 6(d). Such transfer and assumption shall not release the Buyer or Company from its obligations under this Section 6(d). Prior to the Closing, Company will purchase an extended reporting period endorsement under Company's existing directors' and officers'  liability  insurance coverage (“Extended Coverage”) for Company's and its Subsidiaries' directors and officers in a form acceptable to Company which will provide such directors and officers with coverage for six (6) years (or such shorter period permitted by the existing policy) following the Closing, which coverage (to the extent permitted by the existing policy) will be equal to the existing coverage under, and have other terms not materially less favorable to, the insured Persons than the directors' and officers' liability insurance coverage presently maintained by Company. This Section 6(d) is intended to benefit each of the  Indemnified  Persons and their  respective  heirs and personal representatives, each of  whom will be entitled to enforce the provisions hereof. Nothing in this Section 6(d) will be deemed to extend to Sellers (other than Sellers and trustees, officers or directors of Sellers in their capacity as officers or directors of Company) any rights of directors, officers or employees provided for herein.
(e)  Seller Release.  By execution of this Agreement, for and in consideration  of the  covenants and promises set forth in this Agreement each Seller, on behalf of himself and his assigns, heirs, beneficiaries, creditors, representatives, agents and affiliates (the "Releasing Parties"), hereby fully and finally releases, acquits and forever discharges Company, the Subsidiaries of Company, each other Company Holder and each of Company's, its Subsidiaries’ and other Company Holder's present and former direct or indirect partners, members and stockholders and the officers, directors, partners, members, stockholders, trustees, shareholders, representatives, employees, agents, affiliates, subsidiaries,  predecessors,  successors, assigns, beneficiaries, heirs, executors, insurers and attorneys of any of them (collectively, the "Released

 
44 

 
 
Parties") from any and all actions, debts, claims, counterclaims, demands, liabilities, damages, causes of action, costs, expenses, and compensation of every kind and nature whatsoever, past, present, or future, at law or in equity, whether known or unknown, which such Releasing Parties, or any of them, had, has, or may have had at any time in the past until and including the date of this Agreement against the Released Parties, or any of them, including but not limited to any claims which relate to or arise out of such Releasing Party's prior relationship with Company or his, her or its rights or status as a stockholder, warrant holder, officer or director of Company, except for claims arising under or pursuant to this Agreement and rights to indemnification, defense  and advancement of expense for directors, officers and employees as provided in Section 6(d) above. Each Seller hereby represents and warrants that he, she or it has adequate information regarding the terms of this Agreement, the scope and effect of the releases set forth in this Section 6(e), and all other matters encompassed by this Section 6(e) to make an informed and knowledgeable decision with regard to this Section 6(e), and that he, she or it has independently and without reliance upon the Released Parties made his, her or its own analysis and decision to enter into this Agreement. Each Seller further agrees not to institute any litigation, lawsuit, claim or action against any Released Party with respect to any and all claims released in this Section 6(e). Each Seller acknowledges that he, she or it has had the benefit of advice of competent legal counsel with respect to his, her or its decision to enter into the release and agreements provided for in this Section 6(e). Each Seller further acknowledges that the consideration payable to him, her or it pursuant to this Agreement provides good and sufficient consideration for the releases and agreements set forth in this Section 6(e). This Section 6(e) is intended to benefit each of the Released Parties and their respective heirs and personal representatives, each whom will be entitled to enforce the provisions hereof.

(f)  Incentive Bonus Payments. Buyer will cause Company to pay the amount of Incentive Bonus payable after Closing to the Persons in the allocations as determined by Company’s Board of Directors prior to Closing.
 
Section 7.          Conditions to Obligation to Close. 

(a) Conditions to Buyer's Obligation.  Buyer's obligation to consummate the Closing is subject to satisfaction of each of the following conditions:

(i) the representations and warranties of Sellers and of Company set forth in this Agreement, including but not limited to those set forth in Section 3(a) and Section 4 above will be true and correct in all material respects as of the Closing Date as if then made, without giving effect to any supplement to the Disclosure Schedule, except to the extent that such representations and warranties are qualified by the term "material," or contain terms such as "Material Adverse Effect" or "Material Adverse Change," in which case such representations and warranties (as so written, including the term "material" or "Material Adverse Effect or “Material Adverse Change") will be true and correct in all respects at and as of the Closing Date as if then made, without giving effect to any supplement to the Disclosure Schedule;

(ii) Company and Stockholders Representative will each have performed and complied with all of their covenants hereunder in all material respects, and Sellers will
 
 
45 

 

have complied with all of their material covenants hereunder in all material respects, through the Closing, except to the extent that such covenants are qualified by the term "material," or contain terms such as "Material Adverse Effect" or "Material Adverse Change," in which case Company and Stockholders Representative will each have performed and complied with all of such covenants in all respects through the Closing, and Sellers will have complied with all of their material covenants hereunder in all respects through Closing, as such covenants are written, including the term "material" or "Material Adverse Effect or “Material Adverse Change";

(iii) there will not be any injunction, judgment, order, decree, ruling, or charge in effect preventing consummation of any of the transactions contemplated by this Agreement;

(iv) Stockholders Representative and Company each will have delivered to Buyer a certificate to the effect that each of the conditions specified above in Section 7(a)(i)-(iii) above is satisfied in all respects, except that the certificate may be qualified to the knowledge of the Stockholders Representative and Company without investigation as to the performance and compliance of the Sellers with their covenants and the accuracy of Sellers’ representations, and which shall also accurately state the amount of all Transaction Expenses incurred from July 1, 2009 through Closing;

(v) Buyer, the Sellers, Company and Company’s Subsidiaries will have received all authorizations, consents, and approvals of Governmental Bodies and other Persons referred to in Section 3(a)(ii), Section 3(b)(ii) and Section 4(c) above, including without limitation approval of any required Form A filings by applicable state insurance regulatory authorities and all such authorizations, consents and approvals will be in full force and effect and will not contain or be subject to any conditions or other requirements not reasonably satisfactory to Buyer;
(vi) Company will have entered into executive employment agreements with Steve Loranger and with Thomas Smith on such terms as may be satisfactory to Buyer and Company;

(vii)  Buyer will have confirmed to its reasonable satisfaction that the consolidated GAAP book value of Company and its Subsidiaries as at June 30, 2009 was at least Twenty Six Million Five Hundred Thousand Dollars ($26,500,000).

(viii) Company will have delivered to Buyer its GAAP-based financial statements as of and for the most recently available quarterly period prior to Closing prepared in a manner consistent with the Most Recent GAAP Financial Statements and for the most recently available monthly period prior to Closing prepared in a manner consistent with and similar to the monthly financial statements customarily prepared by Company in the Ordinary Course of Business, and Buyer will have confirmed to its reasonable satisfaction that the consolidated GAAP book value of Company and its Subsidiaries as at the end of such quarterly period and monthly period was at least

 
46

 

 
Twenty Six Million Five Hundred Thousand Dollars ($26,500,000) without regard to the impact of Transaction Expenses incurred after June 30, 2009;
 
(ix)  Buyer will have received from counsel to Company an opinion in form and substance reasonably satisfactory to it and its counsel, addressed to Buyer and dated as of the Closing Date;

(x) Stockholders Representative or Company will have obtained and delivered to Buyer Joinder Agreements, and/or written consents to the Merger (in such form as is reasonably acceptable to Buyer), signed by Company Holders representing at least 90% of the Company Shares;

(xi) Neither this Agreement (including the Disclosure Schedule) nor any certificate delivered pursuant hereto will have contained any untrue statement of a material fact relating to Company and its Subsidiaries taken as a whole, or omitted to state a material fact relating to Company and its Subsidiaries taken as a whole necessary to make the statements made, in light of the circumstances in which they are made, not misleading; and

(xii) all actions to be taken by Stockholders Representative or Company in connection with consummation of the transactions contemplated hereby will have been taken and all certificates, opinions, instruments, and other documents required to effect the transactions contemplated hereby will be reasonably satisfactory in form and substance to Buyer.

Buyer may waive, in whole or in part, any condition specified in this Section 7(a) if it executes a writing so stating at or prior to the Closing.
 
(b) Conditions to Sellers’, Stockholders Representative's and Company’s Obligations to Close.   Sellers’, Stockholders Representatives and Company’s obligation to consummate the Closing is subject to satisfaction of each of the following conditions:

(i) the representations and warranties of Buyer set forth in this Agreement, including but not limited to those set forth in Section 3(b) above, will be true and correct in all material respects at and as of the Closing Date, except to the extent that such representations and warranties are qualified by the term "material," or contains terms such as "Material Adverse Effect" or "Material Adverse Change," in which case such representations and warranties (as so written, including the term "material" or "Material Adverse Effect or “Material Adverse Change ") will be true and correct in all respects at and as of the Closing Date;

(ii) Buyer will have performed and complied with all of its covenants hereunder in all material respects through the Closing, except to the extent that such covenants are qualified by terms such as "material" and "Material Adverse Effect," in which case Buyer will have performed and complied with all of such covenants (as so written, including the term "material" or "Material") in all respects through the Closing;

 
47 

 


(iii) there will not be any injunction, judgment, order, decree, ruling, or charge in effect preventing consummation of any of the transactions contemplated by this Agreement;

(iv) Buyer will have delivered to Sellers a certificate to the effect that each of the conditions specified above in Section 7(b)(i)-(iii) above is satisfied in all respects;

(v) each of the Parties and each of Company’s Subsidiaries will have received all other authorizations, consents, and approvals of Governmental Bodies and other Persons referred to in Section 3(a)(ii), Section 3(b)(ii) and Section 4(c) above and all such authorizations, consents and approvals will be in full force and effect and will not contain or be subject to any conditions or other requirements not reasonably satisfactory to Stockholders Representative;

(vi) Stockholders Representative will have received from counsel to Buyer an opinion in form and substance reasonably satisfactory to Stockholders Representative and counsel to Company, addressed to Sellers, and dated as of the Closing Date; and

(vii) all actions to be taken by Buyer in connection with consummation of the transactions contemplated hereby and all certificates, opinions, instruments, and other documents required to effect the transactions contemplated hereby will be reasonably satisfactory in form and substance to Stockholders Representative.
 
The Stockholders Representative may waive, in whole or in part, any condition specified in this Section 7(b) on behalf of all Sellers or any Seller by executing a writing so stating at or prior to the Closing.
 
(c) Conditions to the Merger Closing if the Stock Purchase Closing Has Occurred.  In the event the Stock Purchase Closing has occurred, the Parties’ obligations to consummate the Merger are subject to the satisfaction of the following conditions, and only the following conditions:

(i)  this Agreement will have been approved by the affirmative vote of the holders of Shares of Company to the extent required by Nevada Law and Company’s Articles of Incorporation and Bylaws;
 
(ii)  no Governmental Body will have enacted, issued, promulgated, enforced or entered any law, order, executive order, stay, decree, judgment, injunction or other order or statute, rule or regulation (each an “Order”) that is in final effect and that has the effect of making the acquisition of Shares or Company Warrants by Buyer or Merger Co or any Affiliate of either of them illegal or otherwise preventing or prohibiting consummation of the Merger; provided, however, that each of the Parties will have used commercially reasonable efforts to prevent the entry of any such Order and to appeal the entry thereof as promptly as possible; and

 
 
48

 


(iii)  Company Holders holding Shares, or Company Warrants exercisable for Shares, representing in the aggregate fewer than ten percent (10%) of Company Shares will have satisfied the prerequisites of Nevada Law to demand payment for their Shares under Sections 92A.300 through 92A.500 of Nevada Law, or will have elected, in accordance with the terms of such Company Holders’ Company Warrants, to receive consideration different from the consideration for such Company Warrants or underlying Shares contemplated by the Merger.

(d) Conditions to the Merger Closing if the Stock Purchase Closing Has Not Occurred.  In the event the Stock Purchase Closing has not occurred prior to the Effective Time, the Parties’ obligations to consummate the Merger Closing are subject to the satisfaction of the conditions set forth in Section 7(c) above and, in addition, to their respective conditions set forth in Sections 7(a)(i) through  (xii) above (but excluding Section 7(a)(x) above) and 7(b)(i) through (vii) above.

Section 8.                      Remedies for Breaches of This Agreement.

(a) Survival of Representations and Warranties.  All of the representations and warranties of the Parties contained in this Agreement will survive the Closing hereunder and (other than those contained in Section 3(a)(v), Section 3(a)(vii), Section 4(b), Section 4(i) and Section 4(o) above)  continue in full force and effect through March 31, 2011 and those contained in Section 3(a)(v), Section 3(a)(vii), Section 4(b), Section 4(i) and Section 4(o) above)  will continue in full force and effect through the date on which the last Earnout Payment (as defined in the Earnout Agreement) is required to be made pursuant to the terms of the Earnout Agreement.
(b) Indemnification Provisions for Buyer's Benefit.  Subject to the provisions of Section 5(e) above to the contrary:

(i) If the Closing occurs, in the event that any of Company’s representations or warranties contained in Section 4 above or elsewhere in this Agreement or in any document or certificate delivered to Buyer by Company in connection with this Agreement were breached at any time at or before the Closing, or were inaccurate as of the Closing, or any of its covenants contained herein that were to be performed before the Closing are breached and not cured at or before the Effective Time, and, provided that Buyer makes a written claim for indemnification with respect to such inaccuracy or breach, or with respect to any Third-Party Claim relating to such inaccuracy or breach, to Stockholders Representative after the Closing and within the survival period specified in Section 8(a) above, then Sellers will be obligated to indemnify Buyer from and against all Adverse Consequences by reason of all such inaccuracies and breaches, but solely to the extent such Adverse Consequences are equal to or less than an aggregate ceiling equal to the Additional Consideration, if any, payable by Buyer to Sellers under the Earnout Agreement (the "Indemnification Ceiling"); provided, however, Buyer will have no right to indemnification hereunder for breaches of or inaccuracies in Company’s representations and warranties except to the extent Buyer has suffered Adverse Consequences by reason of all such breaches and inaccuracies in excess of One Hundred Thousand Dollars ($100,000).  To the extent that Buyer's Adverse Consequences in
 
49

 
 
excess of One Hundred Thousand Dollars ($100,000) by reason of all such inaccuracies and breaches are equal to or less than the Indemnification Ceiling, the Sellers as a group (by action of the Stockholders Representative) will indemnify Buyer from and against any such excess Adverse Consequences Buyer will suffer (including any Adverse Consequences Buyer will suffer after the end of any applicable survival period) caused proximately by the inaccuracy or breach, provided such indemnification, if any, may solely be obtained by reducing the Additional Consideration, if any, as may be otherwise payable by Buyer, and in no event will exceed, in aggregate, the Indemnification Ceiling.  To the extent that Buyer's Adverse Consequences by reason of all such breaches and inaccuracies exceed the Indemnification Ceiling, or to the extent that any claims for indemnification are made after the end of any applicable survival period, Sellers will have no obligation to indemnify Buyer from and against such Adverse Consequences in excess of the Indemnification Ceiling or that relate solely to a claim made after the end of the applicable survival period.

(ii) In the event that any of a Seller’s representations and warranties in Section 3(a) above are breached, at any time at or before the Closing, or were inaccurate as of the Closing, or any of his, her or its covenants contained herein are breached and not cured at or before the Closing, then such Seller, severally and individually but not jointly with other Sellers, will indemnify Buyer from and against the entirety of any Adverse Consequences Buyer will suffer (including any Adverse Consequences Buyer will suffer after the end of any applicable survival period) caused proximately by such inaccuracy or breach, up to the amount of such Seller’s Allocable Portion of the Closing Consideration and of the Additional Consideration.  To the extent that Buyer's Adverse Consequences by reason of all such breaches with respect to such Seller exceed such Seller’s Allocable Portion of the Indemnification Ceiling, or to the extent that any claims for indemnification are made after the end of any applicable survival period, such Seller will have no obligation to indemnify Buyer from and against such Adverse Consequences in excess of such Seller’s Allocable Portion of the Indemnification Ceiling or that relate solely to a claim made after the end of the applicable survival period.
 
(c) Indemnification Provisions for Sellers' Benefit.   In the event that any of Buyer’s representations or warranties contained Section 3(b) above, or elsewhere in this Agreement or in any document or certificate delivered to Company or Sellers by Buyer in connection with this Agreement, are breached, at any time at or before the Closing, or were inaccurate as of the Closing, or any of its covenants contained herein are breached and not cured at or before the Closing, and provided that Stockholders Representative makes a written claim for indemnification against Buyer with respect to such breach after the Closing and within the survival period specified in Section 8(a) above), then Buyer will indemnify each Seller from and against the entirety of any Adverse Consequences such Seller will suffer (including any Adverse Consequences suffered after the end of any applicable survival period) caused proximately by the breach or inaccuracy, provided such indemnification, if any, in no event will exceed, in the aggregate with respect to all Sellers, the Indemnification Ceiling or, with respect to any single Seller, such Seller’s Allocable Portion of the Indemnification Ceiling.  To the extent that Adverse Consequences of all Sellers by reason of all such breaches and inaccuracies exceed the Indemnification Ceiling, or to the extent that Adverse Consequences of any single Seller by
 
50

 


reason of all such breaches and inaccuracies exceed such Seller’s Allocable Portion of the Indemnification Ceiling, or to the extent that any such claims for indemnification are made after the end of any applicable survival period, Buyer will have no obligation to indemnify Sellers or such Seller, as the case may be, from and against such Adverse Consequences in excess of the Indemnification Ceiling or any single Seller’s Allocable Portion of the Indemnification Ceiling or that relate solely to a claim made after the end of the applicable survival period.

(d) Matters Involving Third Parties.  Promptly after receipt by a Party seeking indemnification hereunder (an "Indemnified Party") of notice of any claim or the commencement by any third party or dissenting Company Holder (a “Third Party Claim”) of any claim or proceeding that might result in another Party hereto (the "Indemnifying Party") becoming obligated to indemnify or make any other payment to the Indemnified Party under this Agreement, the Indemnified Party shall notify the Indemnifying Party forthwith in writing of the commencement thereof or of the claim, and shall furnish the Indemnifying Party with all information and documents relating thereto promptly after its receipt thereof. The failure of the Indemnified Party to so notify the Indemnifying Party shall not relieve the Indemnifying Party from any liability that it may have on account of this indemnification or otherwise, except and only to the extent that the Indemnifying Party is prejudiced thereby. The Indemnifying Party shall have the right, within thirty (30) days after being so notified, to assume and control the defense of such claim or proceeding with counsel reasonably satisfactory to the Indemnified Party in good faith and at the Indemnifying Party's own expense; provided that unless and until the Indemnifying Party shall assume such defense pursuant to this sentence, the Indemnified Party shall have the right to conduct and control the defense of such claim or proceeding (including the settlement thereof) without the Indemnifying Party's consent and shall be entitled to payment from the Indemnifying Party of all reasonable costs of such defense (including attorney's fees and expenses and costs of appeals and experts). In any such claim or proceeding the defense of which the Indemnifying Party shall have so assumed, the Indemnified Party shall have the right to participate therein and retain its own counsel at its own expense, unless (i) the Indemnifying Party and the Indemnified Party shall have mutually agreed to the retention of the same counsel or (ii) the named parties to any such proceeding (including impleaded parties) include both the Indemnifying Party and the Indemnified Party, and representation of such parties by the same counsel would be inappropriate due to actual or potential differing interests between them, in which case, i.e. clause (ii), such separate counsel may be retained by the Indemnified Party at the expense of the Indemnifying Party. The Indemnifying Party may elect to settle any claim or Proceeding defended by it without the written consent of the Indemnified Party provided that such settlement is limited solely to payment of monetary damages that are payable in full by the Indemnifying Party and the Indemnified Party is fully discharged at the time of the settlement from any liability with respect to the claim or proceeding, and the Indemnified Party shall not admit any liability with respect thereto or settle, compromise, pay or discharge the same without the prior written consent of the Indemnifying Party so long as the Indemnifying Party is controlling or defending such claim in good faith. The Indemnifying Party may not enter into any settlement that is not limited solely to payment of monetary damages without the Indemnified Party's prior written consent.  Each of the Parties covenant to use all commercially reasonable efforts to cooperate fully with respect to the defense of any claim, action or proceeding covered by this Section 8(d).

 
51 

 


           (e) Treatment of Insurance Proceeds in Relation to Indemnification Payments.   All indemnification payments under this Section 8 will be paid by the Indemnifying Party net of insurance proceeds obtained by the Indemnified Party.

(f) Exclusive Remedy.   Except with respect to claims of fraud or willful misconduct, or claims under federal or state securities laws, if the Closing occurs this Section 8 will provide the sole and exclusive remedy for, any and all Adverse Consequences sustained or incurred by any Indemnified Party with respect to the representations and warranties of this Agreement and with respect to the agreements and covenants contained in this Agreement that are to be performed before the Closing Date.  Nothing contained in this Section 8, however, will limit in any way any Party’s rights if the Closing does not occur for any reason or any Party’s rights, whether or not the Closing occurs, to seek or to obtain specific performance, an injunction or other equitable remedies that may be sought and, to the extent appropriate, obtained in addition to and not in lieu of compensation for Adverse Consequences.
 
 (g) Reduction of Additional Consideration.  With respect to any indemnity obligation arising under Section 8(b)(i) or Section 8(d) above, Buyer's sole recourse for monetary compensation will be the reduction in Additional Consideration, if any, as may be payable to Sellers, in the manner contemplated by the Earnout Agreement.  With respect to any indemnity obligation arising under Section 8(b)(ii) and, regarding cost and expenses, under Section 8(d), Buyer's sole recourse for monetary compensation will be directly against the liable Seller or, after written notice to Stockholders’ Representative, against such Seller’s Allocable Portion of the Additional Consideration, if any, as earned and either paid or to be paid to such Seller, in the manner contemplated by the Earnout Agreement and shall be limited, individually and in the aggregate, to the amount of (i) such Seller’s Allocable Portion of the Closing Consideration  and, if any and in the manner and to the extent contemplated by the Earnout Agreement, Additional Consideration, reduced by (ii) the cumulative sum of any and all amounts recovered by Buyer from such Seller pursuant to Section 8(b)(i), Section 8(b)(ii) or Section 8(d) above.
 
 
Section 9.          Termination. 

(a) Termination of Agreement.  Certain of the Parties may terminate this Agreement as provided below:

(i) Buyer and Stockholders Representative may terminate this Agreement by mutual written consent at any time prior to the Closing;

(ii) Buyer may terminate this Agreement by giving notice to Stockholders Representative at any time prior to September 1, 2009, if Buyer is not reasonably satisfied that the matters disclosed in Section 4(n) of the Disclosure Schedule will be resolved in a manner not materially adverse to the Insurance Subsidiary.  In addition, Buyer may terminate this Agreement by giving notice to Stockholders Representative at any time prior to by giving notice to Stockholders Representative at any time prior to the Closing in the event (A) of any material inaccuracy or breach of any representation or warranty of Company or a

 
52

 
 
Seller contained in this Agreement, if such representation, warranty or covenant is not qualified by the term "material" and does not contain terms such as "Material Adverse Effect" or "Material Adverse Change,” or (B) in the event of any inaccuracy or breach, whether or not material, of any representation or warranty of Company or a Seller contained in this Agreement or in any certificate delivered to Buyer in connection herewith, or of any covenant of Company or a Seller contained in this Agreement, if such representation, warranty or covenant is qualified by the term "material” or contains terms such as "Material Adverse Effect" or "Material Adverse Change," provided in each such case Buyer has notified Stockholders Representative of the inaccuracy or breach, and such inaccuracy or breach has not been cured to the reasonable satisfaction of Buyer within 30 days after the notice of inaccuracy or breach.
 
(iii) Stockholders Representative may terminate this Agreement by giving notice to Buyer at any time prior to the Closing in the event of any material inaccuracy or breach of any representation or warranty of Buyer contained in this Agreement or in any certificate delivered to Stockholders Representative in connection herewith, or of any material covenant of Buyer contained in this Agreement, if such representation, warranty or covenant is not qualified by the term "material" and does not contain terms such as "Material Adverse Effect" or "Material Adverse Change,” or in the event of any inaccuracy or breach, whether or not material, of any representation or warranty of Buyer contained in this Agreement or in any certificate delivered to Stockholders Representative in connection herewith, or of any covenant of Buyer contained in this Agreement, if such representation, warranty or covenant is qualified by the term "material” or contains terms such as "Material Adverse Effect" or "Material Adverse Change," provided in each such case Stockholders Representative has notified Buyer of the inaccuracy or breach, and such inaccuracy or breach has not been cured to the reasonable satisfaction of Stockholders Representative within 30 days after the notice of inaccuracy or breach.
 (iv) Either Buyer or Stockholders Representative may terminate this Agreement by giving notice to the other such Party if the Closing has not occurred within seven months following the date hereof, or such later date as Buyer and Company may agree upon, unless the Party seeking termination is in breach of any of its obligations set forth in Section 5(a) above or is otherwise in material breach of this Agreement.
 
(b) Effect of Termination.  If any Party terminates this Agreement pursuant to Section 9(a) above, all rights and obligations of the Parties hereunder will terminate without any liability of any Party to any other Party (except for any liability of any Party then in breach); provided, however, that the confidentiality provisions contained in Section 5(d) above will survive termination.

Section 10.  Employees; Benefits.

(a) Continuation of Employment Immediately After Closing.   Buyer will ensure that all Persons who were employed by Company or any of its Subsidiaries immediately preceding the Closing Date, including those on vacation, leave of absence or disability (the "Company
 
 
53

 
 
Employees"), will remain employed in a comparable position on and immediately after the Closing, at not less than the same base rate of pay; provided, however, the provisions of this Section 10 shall not apply to any Company Employee that is party to an employment agreement with Company or any of its Subsidiaries or to any action of Buyer, Company or any of its Subsidiaries taken after the Closing Date.
 
(b) Change of Control.  Buyer acknowledges that consummation of the transactions contemplated by this Agreement will constitute a change in control under Company Group Benefit Plans to the extent, if any, set forth on Section 4(o)(vi) of the Disclosure Schedule. From and after the Closing, Buyer will not prevent Company from making any payments required under all such Company Group Benefit Plans at the time and in the amount provided under the terms of such Company Group Benefit Plans.

(c) Period of Service. To the extent that service is relevant for purposes of eligibility, vesting, calculation of any benefit, or benefit accrual under any employee benefit plan, program or arrangement established or maintained by Buyer (other than any defined benefit pension plan) following the Closing Date for the benefit of Company Employees, such plan, program or arrangement will credit such Company Employees for service on or prior to the Closing Date that was recognized by the Company or its Subsidiaries, as the case may be, for purposes of employee benefit plans, programs or arrangements maintained by the Company, except to the extent it would result in a duplication of benefits. In addition, with respect to any welfare benefit plan (as defined in Section 3(1) of ERISA) established or maintained by Buyer following the Closing Date for the benefit of Company Employees, such plan will waive any pre-existing condition exclusions to the extent such condition was covered under a Company Group Benefit Plan immediately preceding the Closing Date and provide that any covered expenses incurred on or before the Closing Date by any Company Employee or by a covered dependent will be taken into account for purposes of satisfying applicable deductible coinsurance and maximum out-of-pocket provisions after the Closing Date.

 (d) No Employee Third Party Beneficiaries.  Nothing in this Agreement will be interpreted or construed to confer any third party rights upon the Company Employees or any other Person who is not a party to this Agreement. This Section 10(d) will be binding on all successors and assigns of Buyer and Company. Notwithstanding the foregoing, (i) nothing in this Agreement will be interpreted or construed to confer upon the Company Employees any right with respect to continuance of employment by the Company, such Subsidiaries or Buyer, nor will this Agreement interfere in any way with the right of the Company, such Subsidiaries or Buyer to terminate any employee's employment at any time and (ii) nothing in this Agreement will interfere in any way with the right of Buyer to amend, terminate or otherwise discontinue any or all plans, practices or policies of Buyer in effect from time to time.

Section 11.                     Miscellaneous.

(a) Nature of Sellers' Obligations.    The covenants of each Seller in Section 2(a) above concerning the sale of his, her, or its Company Shares to Buyer and the representations and warranties of each Seller in Section 3(a) above concerning the transaction are individual and not joint or several obligations. This means that the particular Seller making the representation,
 
 
 
54

 

warranty, or covenant will be solely responsible to the extent provided in Section 8(b)(ii) above for any Adverse Consequences Buyer may suffer as a result of any breach thereof.
 
(b) Nature of Buyer Obligations; Subsidiary Actions. The liabilities and obligations of each Buyer and Merger Co under this Agreement, the Earnout Agreement and any other document, instrument or certificate executed in connection with the transactions contemplated hereby or thereby (collectively “Transaction Documents”) are joint and several. The Knowledge of Merger Co shall be attributed to Buyers, and the Knowledge of any Buyer shall be attributed to Merger Co. and the other Buyer, as the case may be. With respect to any provision in a Transaction Document requiring action to be taken or not taken by a Subsidiary of a Buyer, the parent Buyer undertakes to cause the Subsidiary to take or not take such action, as the case may be. With respect to any provision in a Transaction Document requiring action to be taken or not taken by a Subsidiary of company, Company undertakes to cause the Subsidiary to take or not take such action, as the case may be.
 
(c) Press Releases and Public Announcements.   No Party will issue any press release or make any public announcement relating to the subject matter of this Agreement prior to the Closing without the prior written approval of Buyer and Stockholders Representative, which approval will not be unreasonably withheld; provided, however, that Buyer may make any public disclosure it believes in good faith is required by applicable Legal Requirements or any listing or trading agreement concerning its publicly traded securities (in which case the Buyer will use its commercially reasonable  efforts to advise the other Parties prior to making the disclosure).  The Parties anticipate a press release by Buyer, Company, and Stockholders Representative will be issued within four (4) business days after execution of the Agreement.

(d) No Third-Party Beneficiaries.   This Agreement will not confer any rights or remedies upon any Person other than the Parties and their respective successors and permitted assigns.

(e) No Code §338 Election.   Neither Buyer, Company, nor any of their Affiliates will make any election under Code §338 with respect to the transactions contemplated by this Agreement.

(f) Entire Agreement.   This Agreement (including the documents referred to herein) constitutes the entire agreement among the Parties and supersedes any prior understandings, agreements (other than the Confidentiality Agreement), or representations by or among the Parties, written or oral, to the extent they relate in any way to the subject matter hereof.

(g) Succession and Assignment.   This Agreement will be binding upon and inure to the benefit of the Parties named herein and their respective successors and permitted assigns. No Party may assign either this Agreement or any of his, her, or its rights, interests, or obligations hereunder without the prior written approval of Buyer and Stockholders Representative.

(h) Counterparts.   This Agreement may be executed in one or more counterparts (including by means of facsimile), each of which will be deemed an original but all of which together will constitute one and the same instrument.
 
 
55

 
 
 
(i) Headings.   The section headings contained in this Agreement are inserted for convenience only and will not affect in any way the meaning or interpretation of this Agreement.

(j) Notices.  All notices, requests, demands, claims, and other communications hereunder will be in writing. Any notice, request, demand, claim, or other communication hereunder will be deemed duly given (i) when delivered personally to the recipient, or (ii) when received by the recipient by facsimile transmission or electronic mail and recipient confirms such receipt by facsimile transmission or electronic mail, and addressed to the intended recipient as set forth below:
 
           
If to Sellers:
     Copy to:  
 
Advocate, MD Financial Group      Sandlin Law Firm    
Selling Stockholders   
7000 N. MoPac Expressway, Suite 200
c/o Mark E. Adams 
   Austin, Texas 78731
 
and Timothy P. Reardon
    Attn: Oliver Sandlin  
 
Stockholders Representative
Facsimile: 512 ###-###-####
 
Email: ***@***
 
 
 

If to Stockholders Representative:

Tim Reardon
1000 North Water Street, Suite 2100
Milwaukee, WI 53202
Ofc:  (414) 298-8227
Fax:  (414) 298-8097
***@***

and

Mark Adams
6001 Cervinus Run
Austin, TX  78735
Ofc:  (512) 275-1834
Fax:  (512) 891-0320
***@***
 
           
If to Company:
     Copy to:  
 
Advocate, MD Financial Group      Sandlin Law Firm    
811 Barton Springs Road 
7000 N. MoPac Expressway, Suite 200
Suite 800
   Austin, Texas 78731
 
Austin, TX 78704
    Attn: Oliver Sandlin  
 
Attn:  Mark A. Adams
Facsimile: 512 ###-###-####
Email:   ***@***
Email: ***@***
 
 
 
 
 
 
 
56

 

           
If to Buyer:
     Copy to:  
 
           
FPIC Insurance Group, Inc.
Kirschner & Legler, P.A.
225 Water Street
   50 North Laura Street
 
Suite 1400
     Suite 2900  
 
Jacksonville, Florida 32202
Jacksonville, Florida 32202
Attn: Charles Divita III
Attn: Kenneth M. Kirschner
Facsimile: 904 ###-###-####
Facsimile: 904 ###-###-####
Email: ***@***
Email: ***@***
 
Any Party may change the address to which notices, requests, demands, claims, and other communications hereunder are to be delivered by giving the other Parties notice in the manner herein set forth.

(k) Governing Law.   This Agreement will be governed by and construed in accordance with the domestic laws of the State of Nevada without giving effect to any choice or conflict of law provision or rule (whether of the State of Nevada or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Nevada.

(l) Amendments and Waivers.   No amendment of any provision of this Agreement will be valid unless the same will be in writing and signed by Buyer and Stockholders Representative. No waiver by any Party of any provision of this Agreement or any default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional or not, will be valid unless the same will be in writing and signed by the Party making such waiver, nor will such waiver be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such occurrence.

(m) Severability.   Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction will not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction.

(n) Expenses.   Each of Buyer, Seller, Company, and Company Subsidiary will bear his, her, or its own costs and expenses (including legal fees and expenses) incurred in connection with this Agreement and the transactions contemplated hereby; provided, however, that Company will also bear all of the costs and expenses of Stockholders Representatives, Company and Company's Subsidiaries (including all of their legal fees and expenses, investment banking fees and other transaction expenses) incurred in connection with this Agreement and the transactions contemplated hereby (other than any Income Tax on any gain resulting from the sale of the Company Shares hereunder) from July 1, 2009 through Closing in the event that the transactions contemplated by this Agreement are consummated, including without limitation for Fox-Pitt fees and expenses, legal fees and expenses and actuarial fees and expenses, but only to the extent such costs and expenses reflected as Transaction Expenses on the Stockholders Representative’s certificate delivered to Buyer pursuant to the provisions of Section 7(a)(iv) above.
 
 
 
57

 

 
(o) Construction.   The Parties have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the Parties and no presumption or burden of proof will arise favoring or disfavoring any Party by virtue of the authorship of any of the provisions of this Agreement. Any reference to any federal, state, local, or foreign statute or law will be deemed also to refer to all rules and regulations promulgated thereunder, unless the context requires otherwise. The word "including" will mean including without limitation.  References to “commercially reasonable efforts” shall not require, or be construed to require, a Person to waive any closing condition or take actions that could reasonably be expected to result in a materially adverse change in the benefits to such Person under this Agreement and the transactions contemplated hereby, or to dispose of its business, expend any material funds or incur any other material burden.  Time is of the essence in the Parties’ performance of their respective obligations under this Agreement.

(p) Incorporation of Exhibits, Annexes, and Schedules.   The Exhibits, Annexes, and Schedules identified in this Agreement are incorporated herein by reference and made a part hereof.

   (q) Action by Stockholders Representative. Any action taken by Stockholders Representative, including agreements, waivers, amendments and notices, will not be validly taken unless expressed in a writing signed by the individuals comprising Stockholders Representative.  Buyer is entitled to rely fully on any such action of the Stockholders Representative and each such action shall be binding on the Company Holders.

(r) Dispute Resolution.

(i)  Any dispute between Parties arising out of or relating to this Agreement, including, but not limited to, claims for indemnification pursuant to Section 8 will be resolved in accordance with the procedures specified in this Section 11(r) which will be the sole and exclusive  procedures  for the  resolution  of any  such  disputes.

 (ii)  The Parties will attempt in good faith to resolve any dispute arising out of or relating to this Agreement promptly by negotiation between the Stockholders Representative and officers of Buyer. Any Party may give another Party notice of any dispute not resolved in the normal course of business. Within 10 business days after delivery of the notice, the receiving Party will submit to the other a written response. The notice and response will include (i) a statement of each Party's position, and (ii) the name and title of the individual who will act as such Party's representative. Within 10 business days after delivery of the disputing party's notice, the Stockholders Representative and the Buyer will meet at a mutually acceptable time and place, and thereafter as often as they reasonably deem necessary to attempt to resolve the dispute. All reasonable requests for information made by one Party to the other will be honored. All negotiations pursuant to this clause are confidential and will be treated as compromise and settlement negotiations for purposes of the Federal Rules of Evidence.
 
 
58

 

(iii)  If the matter has not been resolved within 20 business days of the disputing Party's notice, or if the parties fail to meet within 15 business days of such notice, the disputing Party may initiate litigation upon 10 business days’ notice to the other Party, as provided hereinafter; provided, however, that if one Party has requested the other to participate in such  procedures and the other Party has failed to participate, the requesting Party may provide written notice of its intent to initiate litigation prior to the expiration of such periods.
 
(iv) The procedures specified in this Section 11(r) will be the sole and exclusive procedures for the resolution of disputes between the Parties arising out of or relating to this Agreement; provided, however, that any Party may, without prejudice to the above procedures, seek preliminary injunction if in its sole judgment such action is necessary to avoid irreparable damage or to preserve the status quo. Despite such action the Parties will continue to participate in good faith in the procedures specified in this Section 11(r).

(v) All applicable statutes of limitation and defenses based upon the passage of time will be tolled while the procedures specified in Section 11(r) are pending. The Parties will take such action, if any, required to effectuate such tolling.

(vi)  Any judicial proceeding arising out of or relating to this Agreement shall be brought exclusively in the Federal Courts having jurisdiction and sitting in Dallas, Texas. EACH PARTY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF ANY FEDERAL COURT SITTING IN DALLAS, TEXAS, FOR THE PURPOSES OF ANY JUDICIAL SUIT, ACTION OR OTHER PROCEEDING ARISING OUT OF THIS AGREEMENT, THE MERGER AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY. THE PARTIES HEREBY AGREE AND CONSENT THAT, IN ADDITION TO ANY METHODS OF SERVICE OF PROCESS PROVIDED FOR UNDER APPLICABLE LAW, ALL SERVICE OF PROCESS IN ANY SUCH SUIT, ACTION OR PROCEEDING IN ANY FEDERAL COURT SITTING IN DALLAS, TEXAS MAY BE MADE BY CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED, AND SERVICE SHALL BE COMPLETE ON THE DELIVERY OR ATTEMPTED DELIVERY AS EVIDENCED BY THE RETURN RECEIPT. EACH PARTY IRREVOCABLY WAIVES ANY OBJECTION TO THE LAYING OF VENUE OF ANY ACTION, SUIT OR PROCEEDING ARISING OUT OF THIS AGREEMENT, THE MERGER AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY IN ANY FEDERAL COURT SITTING IN DALLAS, TEXAS AND FURTHER IRREVOCABLY WAIVE AND AGREE NOT TO PLEAD OR CLAIM IN ANY SUCH COURT THAT ANY SUCH ACTION, SUIT OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. This provision may be filed with any court as written evidence of the knowing and voluntary irrevocable agreement among the Parties to waive any objections to jurisdiction, to venue or to convenience of forum.  The foregoing consents to jurisdiction and appointments of agents to receive service of process shall not constitute general consents to service of process in the State of Texas for any purpose except as provided above and shall not be deemed to confer rights on any Person other than the Parties to the Merger Agreement. If any such proceeding is necessary to enforce the provisions of this Agreement, including any claim or demand, or to

 
 
59

 
 
to interpret this Agreement, the prevailing Party shall be entitled to recover from the other Party reasonable attorney’s fees, costs, expenses and necessary disbursements in addition to any other relief to which it may otherwise be entitled, whether or not such action or proceeding is prosecuted to judgment.
 
IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above written.
 
 

 
 
 
[SIGNATURE PAGES TO FOLLOW]
 

 
60 

 


 
 

 
FPIC INSURANCE GROUP, INC.


By: /s/ John R. Byers 
Name: John R. Byers 
Title: President and Chief Executive Officer 
 

 
 

 
FIRST PROFESSIONAL INSURANCE
COMPANY, INC.


By: /s/ Charles Divita, III                                                                
Name: Charles Divita, III                                                                
Title: Vice President 



FPIC MERGER CORP.


By: /s/John R. Byers 
Name: John R. Byers 
Title: President                                                                
 
 
 
 
 
 

 
 
61

 




ADVOCATE, MD FINANCIAL GROUP
 INC.


By: /s/ Mark E. Adams                                                                
Name: Mark E. Adams                                                                
Title: President and Chief Executive Officer 



STOCKHOLDERS REPRESENTATIVE


By: /s/ Timothy P. Reardon 
Name: Timothy P. Reardon 
Title: Stockholder Representative               



STOCKHOLDERS REPRESENTATIVE


By: /s/ Mark E. Adams                                                                
Name: Mark E. Adams                                                                
Title: Stockholder Representative     
 
 
                                                           


 
62 

 


 
ANNEX I
 
 
Exceptions to Sellers' Representations and Warranties Concerning Transaction
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
63

 

 
ANNEX II
 
 
Exceptions to Buyer’s Representations and Warranties Concerning Transaction
 
 
Section 3(b)(ii): Buyer is required to file a Form A application with the Texas Department of Insurance and to obtain the approval of the Texas Insurance Commissioner to Buyer’s acquisition of Company and its Subsidiaries.
 
 
 
 
 
 
 
 
 
 
 
 

 
  64